data_1tqz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tqz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.683 HG21 HD12 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.559 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.508 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 ' CE2' ' A' ' 43' ' ' TRP . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 42' ' ' ASP . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.536 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.606 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.93 0.395 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' HZ2' HG12 ' A' ' 22' ' ' ILE . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.611 ' CD2' ' HB3' ' A' ' 20' ' ' TYR . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.665 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.67 ' CE2' HG13 ' A' ' 19' ' ' VAL . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HG3' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.52 ' HD2' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 10' ' ' VAL . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.661 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.619 HD12 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB1' ' HG2' ' A' ' 76' ' ' GLN . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.661 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.59 ' CG1' HG21 ' A' ' 96' ' ' ILE . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HG2' ' HB1' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 81' ' ' ALA . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.989 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 81' ' ' ALA . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 88' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 85' ' ' VAL . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.656 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.582 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.989 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.61 HG23 ' H ' ' A' ' 97' ' ' GLN . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.61 ' H ' HG23 ' A' ' 96' ' ' ILE . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.602 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.655 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HB3' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 121' ' ' VAL . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.609 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 118' ' ' ASP . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.4 m0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.628 0.251 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 126' ' ' HIS . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.727 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.459 ' O ' HG21 ' A' ' 106' ' ' ILE . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.703 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.703 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.758 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.758 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.579 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.722 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HG ' HD23 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.727 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.482 HG12 ' HB3' ' A' ' 12' ' ' CYS . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' N ' HD21 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.587 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.695 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' CB ' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.649 ' H ' HG22 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' ' 93' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.492 HG12 ' CE1' ' A' ' 91' ' ' TYR . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.587 ' HD3' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 103' ' ' SER . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.661 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.619 ' O ' HG22 ' A' ' 100' ' ' THR . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' HD2' ' HD2' ' A' ' 95' ' ' ARG . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 20' ' ' TYR . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' SER . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 118' ' ' ASP . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.518 ' HB3' HG12 ' A' ' 10' ' ' VAL . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.1 m95 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.57 0.224 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 107' ' ' GLY . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.437 HD11 ' OH ' ' A' ' 91' ' ' TYR . 13.8 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.589 HD21 ' CG ' ' A' ' 41' ' ' PRO . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.631 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.669 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.704 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HG ' HD22 ' A' ' 60' ' ' LEU . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.583 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.652 ' CG1' ' HB3' ' A' ' 12' ' ' CYS . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.405 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.552 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.485 HE21 ' HB3' ' A' ' 76' ' ' GLN . 0.0 OUTLIER 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.701 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.559 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.559 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.633 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.592 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.62 ' HG3' ' C ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.56 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.523 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 118' ' ' ASP . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.589 ' ND1' ' HA ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.988 0.423 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.588 ' H ' HG12 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.539 HG13 ' CH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.468 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.786 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.441 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.539 ' CH2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 47' ' ' LEU . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.463 ' HA ' HG13 ' A' ' 10' ' ' VAL . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 76' ' ' GLN . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.697 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.646 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.764 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.82 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.679 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.692 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 81' ' ' ALA . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 93' ' ' VAL . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.767 HG23 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.767 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.457 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE1' ' HA2' ' A' ' 109' ' ' GLY . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.692 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 74' ' ' VAL . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.82 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.684 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 109' ' ' GLY . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 108' ' ' ILE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.502 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.455 ' CD2' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 50' ' ' THR . 26.5 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.069 0.461 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.689 ' O ' HG21 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.702 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 107' ' ' GLY . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.91 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.91 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.846 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' A' ' 58' ' ' ILE . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 49' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.846 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.766 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 20.4 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 98' ' ' ASP . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.709 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.81 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.649 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB3' HE22 ' A' ' 97' ' ' GLN . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 81' ' ' ALA . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.879 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.63 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 93' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' SER . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.586 ' HB2' HG13 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.57 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.689 HG21 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 121' ' ' VAL . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 118' ' ' ASP . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.754 HG23 ' HB3' ' A' ' 126' ' ' HIS . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 50' ' ' THR . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.63 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.566 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.699 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.465 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.699 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.569 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.838 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CG2' ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.648 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.712 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.758 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' OD2' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.712 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 6.7 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.675 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' ILE . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 85' ' ' VAL . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.641 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.523 ' HB3' HG13 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.535 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.52 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.512 HG22 HG12 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.718 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.675 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.675 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.551 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.754 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.512 ' O ' HG11 ' A' ' 13' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 12' ' ' CYS . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG22 ' CZ2' ' A' ' 36' ' ' TRP . 1.3 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 89' ' ' SER . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CZ2' HG22 ' A' ' 22' ' ' ILE . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 41' ' ' PRO . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.591 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.756 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.99 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.576 ' CZ ' HH12 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.566 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.578 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 HG21 HG22 ' A' ' 49' ' ' ILE . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.99 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.665 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.7 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.545 HG13 ' H ' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.821 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.727 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.602 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 105' ' ' PHE . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.799 HD11 HG12 ' A' ' 94' ' ' ILE . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 108' ' ' ILE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.637 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.637 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.669 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.688 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.968 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.469 HG22 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' O ' ' CG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.678 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.706 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.706 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.746 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.731 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.66 HG11 ' CZ2' ' A' ' 43' ' ' TRP . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' H ' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.56 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.66 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.687 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.657 ' HB2' HG13 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.678 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 64' ' ' VAL . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.746 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 62' ' ' ASP . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HZ ' ' HZ2' ' A' ' 59' ' ' LYS . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 56' ' ' ALA . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.675 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 81' ' ' ALA . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.534 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 89' ' ' SER . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.697 ' H ' HG22 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' HE1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.645 HG23 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.941 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 96' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.66 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.588 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.941 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 94' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG13 HG23 ' A' ' 94' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.599 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 118' ' ' ASP . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 11' ' ' LEU . 2.7 m-70 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' C ' ' HG ' ' A' ' 11' ' ' LEU . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.725 ' HA ' HG21 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.583 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.543 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.668 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 16.7 mmt-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.561 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.668 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.424 ' HA ' ' HB3' ' A' ' 76' ' ' GLN . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CG2' HG22 ' A' ' 49' ' ' ILE . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.741 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.741 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.496 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.75 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.669 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.669 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 82' ' ' VAL . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.523 ' HA ' HG21 ' A' ' 85' ' ' VAL . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.659 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 102' ' ' ARG . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 78' ' ' PRO . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.732 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' HG11 ' A' ' 19' ' ' VAL . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.659 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.543 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.479 ' O ' HG21 ' A' ' 121' ' ' VAL . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 118' ' ' ASP . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.432 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.732 0.301 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.5 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.841 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.654 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.563 HG12 ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.644 ' CE2' ' HA3' ' A' ' 107' ' ' GLY . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 34' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.331 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.475 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 32' ' ' ARG . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' CD2' ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.566 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CH2' HG11 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.844 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.563 ' HG ' HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.841 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.579 HG22 HG12 ' A' ' 58' ' ' ILE . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 75' ' ' GLU . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.615 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.579 HG12 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.635 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.635 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 2.6 mp0 -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.579 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.712 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 81' ' ' ALA . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.522 HG22 ' C ' ' A' ' 81' ' ' ALA . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 88' ' ' SER . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.596 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 85' ' ' VAL . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.536 ' CD2' ' CD2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.598 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 1.027 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 95' ' ' ARG . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 97' ' ' GLN . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.834 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.556 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 18' ' ' SER . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.52 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.515 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.515 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 118' ' ' ASP . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 123' ' ' LEU . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.443 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.771 0.32 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.05 -36.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.89 117.99 22.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.211 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -36.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.752 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 pp -150.13 128.62 12.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' O ' ' HD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -86.63 147.67 25.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.51 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.515 ' HD1' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -152.2 170.93 18.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 110.685 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t -159.16 120.96 3.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.683 HG21 HD12 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.559 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 63' ' ' LYS . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.508 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 ' CE2' ' A' ' 43' ' ' TRP . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.665 ' CD2' ' HB3' ' A' ' 42' ' ' ASP . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.606 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -135.31 137.87 27.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 22' ' ' ILE . 2.0 Cg_endo -42.08 131.78 4.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.704 2.269 . . . . 0.0 112.244 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.91 78.76 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.382 2.054 . . . . 0.0 111.368 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.74 150.72 50.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.64 117.35 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.532 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 m -106.42 15.5 25.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.002 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -166.47 -160.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.596 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -116.22 -49.82 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.24 124.25 9.88 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.73 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -176.61 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.62 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -161.48 64.0 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.503 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.582 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' HZ2' HG12 ' A' ' 22' ' ' ILE . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.611 ' CD2' ' HB3' ' A' ' 20' ' ' TYR . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.665 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.67 ' CE2' HG13 ' A' ' 19' ' ' VAL . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HG3' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.52 ' HD2' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.683 HD12 HG21 ' A' ' 10' ' ' VAL . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.661 ' HG3' ' HE1' ' A' ' 57' ' ' TYR . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.619 HD12 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB1' ' HG2' ' A' ' 76' ' ' GLN . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.661 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.59 ' CG1' HG21 ' A' ' 96' ' ' ILE . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HG2' ' HB1' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 81' ' ' ALA . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.989 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 81' ' ' ALA . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 88' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 85' ' ' VAL . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.656 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.582 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.583 HG23 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.989 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.61 HG23 ' H ' ' A' ' 97' ' ' GLN . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.61 ' H ' HG23 ' A' ' 96' ' ' ILE . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.602 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.639 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.536 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.655 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.418 ' HB3' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 121' ' ' VAL . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.609 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 118' ' ' ASP . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.484 ' HE3' HG21 ' A' ' 130' ' ' VAL . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.466 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.4 m0 -91.34 122.11 33.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG21 ' HE3' ' A' ' 128' ' ' LYS . 16.3 t -148.58 -62.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -31.87 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.218 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -156.85 -172.0 3.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.842 0.353 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.65 167.18 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.054 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.45 -64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.327 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -147.61 142.59 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 2.4 tp -153.33 -176.6 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -86.84 105.58 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.63 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.5 96.34 4.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -76.24 164.84 25.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p -77.99 146.6 35.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 126' ' ' HIS . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.512 ' O ' HG12 ' A' ' 13' ' ' VAL . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.727 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' O ' HG21 ' A' ' 106' ' ' ILE . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt -117.34 112.98 39.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -44.5 127.44 7.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.73 171.74 11.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.421 2.081 . . . . 0.0 112.252 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.06 -69.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.85 160.99 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -86.45 60.05 6.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -69.53 141.26 53.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG2' ' H ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -98.55 -52.59 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' H ' ' HG2' ' A' ' 29' ' ' ARG . . . -75.37 94.84 0.94 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.753 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.21 -178.37 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.2 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 74.45 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.777 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.703 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.703 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.758 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.758 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.579 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.722 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' HG ' HD23 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.727 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.482 HG12 ' HB3' ' A' ' 12' ' ' CYS . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.587 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 70' ' ' ALA . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' N ' HD21 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.587 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.695 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' CB ' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.649 ' H ' HG22 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.492 ' CE1' HG12 ' A' ' 93' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.492 HG12 ' CE1' ' A' ' 91' ' ' TYR . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.456 HG12 HD11 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.587 ' HD3' ' CB ' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 103' ' ' SER . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.661 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.619 ' O ' HG22 ' A' ' 100' ' ' THR . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' HD2' ' HD2' ' A' ' 95' ' ' ARG . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 20' ' ' TYR . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' SER . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 118' ' ' ASP . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.518 ' HB3' HG12 ' A' ' 10' ' ' VAL . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.605 ' CE3' ' HA ' ' A' ' 133' ' ' GLU . 25.1 m95 -86.28 109.03 18.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 129' ' ' TRP . 13.1 t -142.46 -46.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -53.15 4.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -150.94 143.89 24.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.792 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.605 ' HA ' ' CE3' ' A' ' 129' ' ' TRP . 4.4 pm0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptm . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.02 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.03 115.92 21.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.619 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 20.7 tt0 -146.14 165.51 28.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.659 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' HG ' ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.22 93.93 2.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.797 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -149.65 78.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.29 126.95 4.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.603 ' CG ' ' HA2' ' A' ' 53' ' ' GLY . 3.3 pt-20 -153.43 115.54 4.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.469 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.32 138.95 12.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.62 ' HG3' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 107' ' ' GLY . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.437 HD11 ' OH ' ' A' ' 91' ' ' TYR . 13.8 mt -121.73 66.34 19.92 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -42.99 120.1 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.82 2.346 . . . . 0.0 112.014 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 78.1 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.421 2.08 . . . . 0.0 112.188 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -131.66 46.37 2.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.207 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.89 165.63 24.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.556 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.3 43.43 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 110.877 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -159.58 133.98 7.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -52.23 -42.61 63.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.85 -173.98 37.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.206 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.24 131.81 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 -65.15 161.65 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.041 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.589 HD21 ' CG ' ' A' ' 41' ' ' PRO . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.631 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.669 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.704 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 44' ' ' THR . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' HG ' HD22 ' A' ' 60' ' ' LEU . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.583 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.652 ' CG1' ' HB3' ' A' ' 12' ' ' CYS . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.603 ' HA2' ' CG ' ' A' ' 8' ' ' GLU . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' SER . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.58 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.709 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.552 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.485 HE21 ' HB3' ' A' ' 76' ' ' GLN . 0.0 OUTLIER 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.701 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.559 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.559 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.633 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.592 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.62 ' HG3' ' C ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.537 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.56 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.523 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 118' ' ' ASP . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.589 ' ND1' ' HA ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -89.38 81.28 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 -52.25 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.375 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -150.11 -147.21 0.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.675 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.99 120.96 4.72 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.995 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.78 146.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.99 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.26 -5.7 58.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -148.74 110.29 4.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.32 146.64 26.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.984 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -146.4 57.79 1.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.59 123.4 27.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.67 97.39 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -158.65 128.46 5.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.28 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.588 ' H ' HG12 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 HG13 ' CH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.468 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.463 ' CG2' ' HD2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -133.78 138.93 32.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.463 ' HD2' ' CG2' ' A' ' 22' ' ' ILE . 1.9 Cg_endo -42.69 173.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.792 2.328 . . . . 0.0 112.37 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.26 106.21 0.98 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.31 2.006 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.37 176.16 2.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.2 44.84 2.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.804 0.335 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 m -129.82 73.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -121.0 108.68 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -129.11 142.45 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.98 12.44 59.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.669 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.76 110.92 10.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.72 66.42 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.786 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.441 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.539 ' CH2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG3' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 47' ' ' LEU . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.463 ' HA ' HG13 ' A' ' 10' ' ' VAL . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.674 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.674 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.794 ' HB1' ' HB3' ' A' ' 76' ' ' GLN . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.697 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.606 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.646 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.794 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.764 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.82 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.679 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.692 ' HB2' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 81' ' ' ALA . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 93' ' ' VAL . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.767 HG23 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.767 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.457 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' CE1' ' HA2' ' A' ' 109' ' ' GLY . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.692 ' HD3' ' HB2' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 74' ' ' VAL . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.82 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.684 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 109' ' ' GLY . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.589 ' N ' HG23 ' A' ' 108' ' ' ILE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.502 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.591 ' O ' HG23 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' HA ' HG23 ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.455 ' CD2' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.42 82.93 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.7 t -150.91 25.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.292 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -87.98 -43.23 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.82 134.71 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.919 0.39 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.91 176.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.301 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.14 166.9 28.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.443 ' O ' HD22 ' A' ' 5' ' ' LEU . 7.0 pt-20 -149.05 131.52 15.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -140.05 119.22 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.7 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.49 90.77 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.91 -171.81 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.56 103.83 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.431 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 50' ' ' THR . 26.5 t -157.44 123.02 4.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.151 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.689 ' O ' HG21 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.702 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 107' ' ' GLY . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.91 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.9 mm -112.24 81.46 3.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.655 ' HD3' ' HG3' ' A' ' 21' ' ' ARG . 1.7 Cg_endo -43.88 140.23 5.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.82 2.347 . . . . 0.0 112.507 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.99 100.46 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.49 2.127 . . . . 0.0 112.09 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.12 -74.87 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.78 94.47 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.17 112.99 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.39 -88.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.353 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.78 -37.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.853 0.359 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.7 142.4 15.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.144 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' HE2' ' HA ' ' A' ' 36' ' ' TRP . 8.2 t80 -166.63 -165.83 0.79 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.907 -0.172 . . . . 0.0 110.698 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.54 139.01 20.49 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.569 HD13 ' HG2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.91 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.846 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD12 ' CG2' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.542 HG21 ' CG2' ' A' ' 58' ' ' ILE . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.486 HG23 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.94 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.94 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 49' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.846 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.766 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.766 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 20.4 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 98' ' ' ASP . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.709 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.81 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.649 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB3' HE22 ' A' ' 97' ' ' GLN . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 81' ' ' ALA . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.879 HG22 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.879 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.63 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.623 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 93' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' SER . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.81 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.586 ' HB2' HG13 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.57 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.689 HG21 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.63 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.444 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 121' ' ' VAL . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 118' ' ' ASP . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.821 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.821 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -147.35 163.53 36.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.5 t -145.26 -47.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 44.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.641 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.14 91.8 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.017 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.745 179.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.665 0.269 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 115.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.834 0.35 . . . . 0.0 111.208 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.78 134.81 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 61.71 3.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.21 -25.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.561 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 7' ' ' TYR . 3.0 mt-10 -146.23 67.3 1.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.371 . . . . 0.0 110.692 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 6' ' ' GLU . 40.9 m-85 -153.98 115.69 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -154.99 134.99 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p -162.7 125.63 2.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.754 HG23 ' HB3' ' A' ' 126' ' ' HIS . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' A' ' 50' ' ' THR . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.575 ' OG ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.576 HG23 ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -124.87 113.19 26.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.556 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -41.78 -52.62 3.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.737 2.291 . . . . 0.0 112.762 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 22' ' ' ILE . 37.2 Cg_endo -64.22 108.67 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.128 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -137.01 50.05 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.88 35.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -147.85 179.23 7.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.971 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -130.71 83.92 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.64 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.22 -172.43 13.64 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 3.9 t80 -166.76 142.05 4.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -65.51 157.24 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.903 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.63 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.699 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.465 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.699 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.569 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.838 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' CG2' ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.648 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.712 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.758 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' OD2' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.712 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 6.7 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.648 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.675 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' ILE . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 85' ' ' VAL . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.641 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.523 ' HB3' HG13 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.63 ' CE1' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.535 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HB2' ' NH1' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.52 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.512 HG22 HG12 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.718 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.675 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.675 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.551 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.587 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.515 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.754 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.51 130.75 36.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.5 t -150.5 -54.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -88.25 52.95 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -83.09 81.94 8.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.81 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.99 107.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.186 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 98.97 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 5' ' ' LEU . 2.8 tt0 -152.03 174.44 13.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.412 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 3.2 tp -143.78 63.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 110.712 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -152.35 66.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 -178.77 6.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.99 100.15 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.49 121.93 3.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.512 ' O ' HG11 ' A' ' 13' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 12' ' ' CYS . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 42' ' ' ASP . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' HB3' ' CB ' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG22 ' CZ2' ' A' ' 36' ' ' TRP . 1.3 mp -114.76 74.05 3.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.85 117.74 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 112.585 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 162.18 41.0 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.464 2.109 . . . . 0.0 112.213 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -131.0 -70.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.94 67.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.188 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -165.0 161.43 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.71 -65.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.743 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 140.85 45.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.12 146.89 18.45 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.25 117.3 14.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.896 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -61.03 147.08 44.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 89' ' ' SER . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CZ2' HG22 ' A' ' 22' ' ' ILE . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 41' ' ' PRO . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.591 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.756 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.507 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.99 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.576 ' CZ ' HH12 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HG23 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.566 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.578 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 HG21 HG22 ' A' ' 49' ' ' ILE . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.99 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 60' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.665 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.7 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.545 HG13 ' H ' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.821 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.821 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.727 ' HB3' HG13 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.602 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.579 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.535 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 105' ' ' PHE . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.799 HD11 HG12 ' A' ' 94' ' ' ILE . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 108' ' ' ILE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.637 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.637 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.465 HG22 ' CZ ' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.669 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.688 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -91.12 125.4 35.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.5 t -149.52 -46.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.586 ' HB3' ' HZ1' ' A' ' 131' ' ' LYS . 0.1 OUTLIER -87.99 61.45 6.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.316 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.49 85.43 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.74 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.772 -179.776 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.666 0.27 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.6 -55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 111.132 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.13 45.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.515 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -149.21 10.91 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -150.29 75.03 1.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 110.155 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.5 105.32 5.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -80.95 128.41 33.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.876 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 83.92 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.683 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -158.18 127.49 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.968 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.469 HG22 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' O ' ' CG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.678 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.706 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.706 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.746 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.731 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.66 HG11 ' CZ2' ' A' ' 43' ' ' TRP . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CD2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.91 82.86 16.96 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 3.1 Cg_exo -42.18 -53.52 3.54 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.686 2.258 . . . . 0.0 112.794 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 41.4 Cg_endo -67.15 -166.19 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.299 2.0 . . . . 0.0 112.075 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.418 ' C ' ' H ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -173.61 75.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.583 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' HH2' ' A' ' 36' ' ' TRP . . . -78.95 27.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -178.67 130.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -46.05 -33.86 3.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.282 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -146.35 154.32 41.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.94 150.45 51.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.519 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' CE1' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -167.13 127.37 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 69.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' H ' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.56 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.66 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.687 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.657 ' HB2' HG13 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.678 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' CB ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 71' ' ' GLN . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 64' ' ' VAL . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.746 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 62' ' ' ASP . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' HZ ' ' HZ2' ' A' ' 59' ' ' LYS . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 56' ' ' ALA . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.675 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.675 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.613 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 81' ' ' ALA . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.534 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' H ' ' A' ' 89' ' ' SER . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.448 HG23 ' CE1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.556 ' HA ' HG22 ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.697 ' H ' HG22 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.467 ' HE1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.701 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.645 HG23 HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.941 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 96' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.66 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.588 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.941 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 94' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG13 HG23 ' A' ' 94' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.731 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.599 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 118' ' ' ASP . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 11' ' ' LEU . 2.7 m-70 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 -146.01 57.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -145.63 23.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -88.94 -21.38 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -160.03 139.93 11.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.998 179.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.724 0.297 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.79 -176.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.54 80.28 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -143.72 -8.99 0.72 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.702 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.09 74.42 8.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.31 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -148.0 97.97 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.221 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -159.71 -165.27 1.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.775 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.6 77.95 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -157.58 125.68 5.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.883 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' C ' ' HG ' ' A' ' 11' ' ' LEU . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.725 ' HA ' HG21 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.583 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.543 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.668 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -111.49 116.48 50.56 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 35.3 Cg_endo -67.09 -29.67 39.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.379 2.053 . . . . 0.0 113.435 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.634 ' HB2' ' CG ' ' A' ' 29' ' ' ARG . 55.9 Cg_endo -71.9 108.79 2.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.664 1.576 . . . . 0.0 112.263 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -126.77 71.55 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.995 0.426 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.59 178.05 7.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.06 -65.92 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.957 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -83.15 55.91 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.372 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.634 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -131.24 13.27 5.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.06 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.33 144.74 15.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.353 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.14 143.89 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.891 0.377 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 16.7 mmt-85 -67.67 163.74 20.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.561 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.668 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.813 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.424 ' HA ' ' HB3' ' A' ' 76' ' ' GLN . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CG2' HG22 ' A' ' 49' ' ' ILE . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.741 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.741 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.496 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.75 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.669 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.669 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 82' ' ' VAL . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.523 ' HA ' HG21 ' A' ' 85' ' ' VAL . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.659 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.732 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 102' ' ' ARG . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 78' ' ' PRO . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.732 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.54 ' O ' HG11 ' A' ' 19' ' ' VAL . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.659 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.543 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.479 ' O ' HG21 ' A' ' 121' ' ' VAL . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 118' ' ' ASP . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.432 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -153.68 91.06 1.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.4 t -153.57 -54.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -93.1 35.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.94 113.82 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.837 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.894 0.378 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.92 86.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.314 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.24 62.12 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.37 146.77 25.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.22 55.19 2.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -152.85 84.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.21 85.2 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.09 136.8 9.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -162.84 172.04 15.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.5 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.841 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.654 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.563 HG12 ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.644 ' CE2' ' HA3' ' A' ' 107' ' ' GLY . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -113.47 94.49 32.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.566 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.1 Cg_endo -42.92 -47.7 8.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.746 2.297 . . . . 0.0 112.507 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 37.0 Cg_endo -65.19 156.71 61.5 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.009 1.806 . . . . 0.0 112.13 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -96.34 143.67 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.25 86.45 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -57.06 -50.27 73.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.039 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -84.77 -73.38 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HD2' ' OE1' ' A' ' 83' ' ' GLU . 8.7 ttp180 -161.3 178.5 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.0 -85.87 0.81 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 3.2 m-85 -166.0 149.11 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.827 0.346 . . . . 0.0 110.383 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -63.63 161.38 14.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' HB1' ' HE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 32' ' ' ARG . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' CD2' ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.566 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.463 ' CH2' HG11 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.844 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.563 ' HG ' HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.841 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.579 HG22 HG12 ' A' ' 58' ' ' ILE . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' A' ' 75' ' ' GLU . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.615 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.579 HG12 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.635 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.635 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.66 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 2.6 mp0 -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.579 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.712 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 81' ' ' ALA . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 1.027 ' HB3' ' HB2' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.522 HG22 ' C ' ' A' ' 81' ' ' ALA . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' OE1' ' HD2' ' A' ' 29' ' ' ARG . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 88' ' ' SER . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.596 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.452 ' HB3' HG11 ' A' ' 85' ' ' VAL . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.536 ' CD2' ' CD2' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.598 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 1.027 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.405 HG13 ' C ' ' A' ' 95' ' ' ARG . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.52 ' N ' ' HG3' ' A' ' 97' ' ' GLN . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.834 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.556 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 18' ' ' SER . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.52 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.515 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.515 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 118' ' ' ASP . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 123' ' ' LEU . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.427 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.443 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -88.29 130.49 35.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 129' ' ' TRP . 49.1 t -143.57 -62.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -149.23 -169.59 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 8.3 mt-30 -150.71 107.36 3.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.904 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.717 HG12 ' HB2' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.618 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.618 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.803 ' CD2' HD23 ' A' ' 38' ' ' LEU . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.632 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.93 0.395 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 87' ' ' ASP . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.825 ' CZ2' HD13 ' A' ' 38' ' ' LEU . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.825 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HG2' HD21 ' A' ' 38' ' ' LEU . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.68 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' VAL . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HD3' ' HD2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 58' ' ' ILE . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.779 ' HD3' HD11 ' A' ' 55' ' ' ILE . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.779 HD11 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.689 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 60' ' ' LEU . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.805 ' HB1' ' NE ' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 89' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.675 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.675 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.654 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.661 HG12 ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.805 ' NE ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 74' ' ' VAL . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 100' ' ' THR . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.609 HH12 ' HB2' ' A' ' 104' ' ' ALA . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB2' HH12 ' A' ' 102' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.661 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.654 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.547 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 121' ' ' VAL . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 122' ' ' SER . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 117' ' ' PHE . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.4 m0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.628 0.251 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 49' ' ' ILE . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.537 ' HB3' HG12 ' A' ' 49' ' ' ILE . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.757 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.755 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.645 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.608 ' CD2' HD11 ' A' ' 38' ' ' LEU . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.626 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.626 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.755 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.757 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 10' ' ' VAL . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 75' ' ' GLU . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 51' ' ' SER . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 47' ' ' LEU . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.744 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 1.022 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG21 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG13 ' A' ' 85' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 1.022 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.617 ' CD1' HG21 ' A' ' 58' ' ' ILE . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.696 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 99' ' ' GLY . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.629 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.808 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 105' ' ' PHE . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.709 HD12 HG12 ' A' ' 94' ' ' ILE . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.593 ' O ' HG22 ' A' ' 121' ' ' VAL . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 117' ' ' PHE . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.1 m95 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.57 0.224 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.668 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.573 ' HD2' HD23 ' A' ' 38' ' ' LEU . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HZ2' HD22 ' A' ' 38' ' ' LEU . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 36' ' ' TRP . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.669 HD22 ' HZ2' ' A' ' 36' ' ' TRP . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.686 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.771 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.877 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 10' ' ' VAL . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.697 ' OG ' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.743 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 56' ' ' ALA . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 1.2 tt0 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.743 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.643 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HE2' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 5.1 mm-40 -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.637 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.633 ' HZ ' HG12 ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.528 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.613 ' HD1' ' CB ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.988 0.423 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' H ' HG13 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 108' ' ' ILE . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.647 ' HD1' HD13 ' A' ' 38' ' ' LEU . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' OH ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.826 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.826 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 38' ' ' LEU . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.614 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD11 ' HE2' ' A' ' 119' ' ' PHE . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.028 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.729 HD12 HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.685 HG22 HH22 ' A' ' 48' ' ' ARG . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.61 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.627 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 70' ' ' ALA . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 3.3 pm0 -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.819 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.731 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HG21 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 85' ' ' VAL . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.579 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.587 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.847 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.698 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 18' ' ' SER . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.557 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CD2' HG21 ' A' ' 17' ' ' VAL . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 50' ' ' THR . 26.5 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.069 0.461 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.678 ' HE2' HD12 ' A' ' 38' ' ' LEU . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.993 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 21' ' ' ARG . 5.9 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.905 HD11 ' HD2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 38' ' ' LEU . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.715 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.915 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.889 HD11 HG22 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.616 ' CD1' HG21 ' A' ' 10' ' ' VAL . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.509 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.95 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.95 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.704 HG21 ' CD1' ' A' ' 96' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 64' ' ' VAL . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.768 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 15.8 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.622 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 76' ' ' GLN . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.758 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.691 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.691 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 94' ' ' ILE . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.637 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.48 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.731 HG22 HG13 ' A' ' 82' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 58' ' ' ILE . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.846 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' HG12 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.586 ' CD1' HD11 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 108' ' ' ILE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' PHE . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 49' ' ' ILE . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.591 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.686 ' CD2' HD23 ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.678 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.588 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.715 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.861 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.654 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 54' ' ' LYS . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.681 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.747 HG22 HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.726 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' OD1' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.726 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 3.0 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.726 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 89' ' ' SER . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.783 ' O ' HG11 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.736 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.59 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HB2' ' NH2' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.534 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.739 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.635 HG22 HG13 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.752 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 49' ' ' ILE . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 48' ' ' ARG . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.793 HG22 HG12 ' A' ' 108' ' ' ILE . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 38' ' ' LEU . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' HE1' ' A' ' 105' ' ' PHE . 1.3 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.501 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.006 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 20' ' ' TYR . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.753 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.55 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.001 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.658 ' CD1' HG21 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 76' ' ' GLN . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 1.001 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' OD1' ' A' ' 62' ' ' ASP . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.758 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.707 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.71 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.006 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.693 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.847 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.749 HG12 HD12 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.617 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.585 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.758 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 107' ' ' GLY . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 106' ' ' ILE . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.793 HG12 HG22 ' A' ' 19' ' ' VAL . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.656 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.656 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.63 HG21 ' CE2' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.968 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG23 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.729 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 18' ' ' SER . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.765 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.621 ' N ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.699 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB2' HG12 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.615 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.778 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 2.0 pt20 -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.745 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.72 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.72 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.631 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.566 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.621 ' HG1' ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.918 ' HB3' HG11 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.628 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.824 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.727 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.956 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.598 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' A' ' 80' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.745 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.463 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 108' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 106' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 121' ' ' VAL . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 2.3 t-20 -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.475 HG11 ' CE1' ' A' ' 117' ' ' PHE . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 49' ' ' ILE . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.625 HG11 ' NH1' ' A' ' 48' ' ' ARG . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' VAL . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' CZ3' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.512 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 16.7 mmt-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB2' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.847 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.625 ' NH1' HG11 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.792 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 75' ' ' GLU . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.748 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.748 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.703 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 55' ' ' ILE . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.803 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' H ' ' A' ' 89' ' ' SER . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.597 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.727 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.661 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.634 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.528 ' CB ' HG13 ' A' ' 74' ' ' VAL . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.621 ' C ' HG23 ' A' ' 100' ' ' THR . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.661 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 12' ' ' CYS . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.527 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.481 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.527 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.732 0.301 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.676 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.863 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.649 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' CG1' ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 22' ' ' ILE . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.693 ' C ' HD13 ' A' ' 22' ' ' ILE . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.71 HD11 ' CE2' ' A' ' 20' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HB2' ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.331 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.518 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.551 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.875 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 12' ' ' CYS . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 56' ' ' ALA . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' C ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.642 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.013 HG11 HG21 ' A' ' 96' ' ' ILE . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.761 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.903 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 97' ' ' GLN . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.682 ' C ' ' HD3' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG12 ' OH ' ' A' ' 20' ' ' TYR . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.614 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.013 HG21 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.649 ' HB2' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 102' ' ' ARG . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.903 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.584 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.666 ' HA3' ' CE2' ' A' ' 20' ' ' TYR . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 94' ' ' ILE . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.52 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.52 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 117' ' ' PHE . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' HB2' HG13 ' A' ' 10' ' ' VAL . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.44 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.771 0.32 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.05 -36.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.89 117.99 22.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.211 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -36.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.752 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 5' ' ' LEU . 3.8 pp -150.13 128.62 12.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -86.63 147.67 25.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.51 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.517 ' HD1' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -152.2 170.93 18.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 110.685 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t -159.16 120.96 3.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.717 HG12 ' HB2' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.618 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.618 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.803 ' CD2' HD23 ' A' ' 38' ' ' LEU . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.632 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -135.31 137.87 27.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.08 131.78 4.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.704 2.269 . . . . 0.0 112.244 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.91 78.76 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.382 2.054 . . . . 0.0 111.368 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.74 150.72 50.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.64 117.35 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.532 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 m -106.42 15.5 25.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.002 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -166.47 -160.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.596 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -116.22 -49.82 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.24 124.25 9.88 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.73 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -176.61 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.62 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -161.48 64.0 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.503 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 87' ' ' ASP . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.825 ' CZ2' HD13 ' A' ' 38' ' ' LEU . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.825 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HG2' HD21 ' A' ' 38' ' ' LEU . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.68 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' VAL . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HD3' ' HD2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 58' ' ' ILE . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.779 ' HD3' HD11 ' A' ' 55' ' ' ILE . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.779 HD11 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.689 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 60' ' ' LEU . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.805 ' HB1' ' NE ' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 89' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.675 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.675 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.654 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.661 HG12 ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.805 ' NE ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 74' ' ' VAL . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 100' ' ' THR . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.609 HH12 ' HB2' ' A' ' 104' ' ' ALA . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB2' HH12 ' A' ' 102' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.661 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.654 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.547 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 121' ' ' VAL . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 122' ' ' SER . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 117' ' ' PHE . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HE3' HG21 ' A' ' 130' ' ' VAL . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -91.34 122.11 33.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.618 HG21 ' HE3' ' A' ' 128' ' ' LYS . 16.3 t -148.58 -62.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -31.87 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.218 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -156.85 -172.0 3.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.842 0.353 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.65 167.18 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.054 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.45 -64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.327 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -147.61 142.59 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 2.4 tp -153.33 -176.6 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -86.84 105.58 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.63 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.5 96.34 4.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -76.24 164.84 25.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p -77.99 146.6 35.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 49' ' ' ILE . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.537 ' HB3' HG12 ' A' ' 49' ' ' ILE . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.757 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.755 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.645 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.608 ' CD2' HD11 ' A' ' 38' ' ' LEU . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt -117.34 112.98 39.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 1.7 Cg_endo -44.5 127.44 7.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.73 171.74 11.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.421 2.081 . . . . 0.0 112.252 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.06 -69.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.85 160.99 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -86.45 60.05 6.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -69.53 141.26 53.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -98.55 -52.59 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 29' ' ' ARG . . . -75.37 94.84 0.94 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.753 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.21 -178.37 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.2 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 74.45 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.777 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.626 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.626 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.755 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.757 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 10' ' ' VAL . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 75' ' ' GLU . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 51' ' ' SER . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 47' ' ' LEU . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.744 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 1.022 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG21 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG13 ' A' ' 85' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 1.022 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.617 ' CD1' HG21 ' A' ' 58' ' ' ILE . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.696 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 99' ' ' GLY . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.629 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.808 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 105' ' ' PHE . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.709 HD12 HG12 ' A' ' 94' ' ' ILE . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.593 ' O ' HG22 ' A' ' 121' ' ' VAL . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 117' ' ' PHE . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.619 ' CE3' ' HA ' ' A' ' 133' ' ' GLU . 25.1 m95 -86.28 109.03 18.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 t -142.46 -46.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -53.15 4.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -150.94 143.89 24.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.792 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.619 ' HA ' ' CE3' ' A' ' 129' ' ' TRP . 4.4 pm0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptm . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.02 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.03 115.92 21.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.619 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 20.7 tt0 -146.14 165.51 28.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.659 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.22 93.93 2.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.797 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -149.65 78.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.29 126.95 4.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.627 ' CG ' ' HA2' ' A' ' 53' ' ' GLY . 3.3 pt-20 -153.43 115.54 4.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.469 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.32 138.95 12.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.668 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.573 ' HD2' HD23 ' A' ' 38' ' ' LEU . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -121.73 66.34 19.92 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -42.99 120.1 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.82 2.346 . . . . 0.0 112.014 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 78.1 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.421 2.08 . . . . 0.0 112.188 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -131.66 46.37 2.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.207 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.89 165.63 24.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.556 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.3 43.43 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 110.877 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -159.58 133.98 7.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -52.23 -42.61 63.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.85 -173.98 37.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.206 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.24 131.81 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 19.0 ptt-85 -65.15 161.65 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.041 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HZ2' HD22 ' A' ' 38' ' ' LEU . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 36' ' ' TRP . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.669 HD22 ' HZ2' ' A' ' 36' ' ' TRP . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.771 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.877 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 10' ' ' VAL . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.697 ' OG ' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 8' ' ' GLU . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.743 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 56' ' ' ALA . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 1.2 tt0 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.743 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.643 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HE2' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 5.1 mm-40 -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.637 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.633 ' HZ ' HG12 ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.528 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.55 ' OD1' HG11 ' A' ' 130' ' ' VAL . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.613 ' HD1' ' CB ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -89.38 81.28 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.55 HG11 ' OD1' ' A' ' 125' ' ' ASP . 97.5 t -93.19 -52.25 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.375 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -150.11 -147.21 0.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.675 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.99 120.96 4.72 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.995 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.78 146.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.99 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.26 -5.7 58.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -148.74 110.29 4.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.32 146.64 26.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.984 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -146.4 57.79 1.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.59 123.4 27.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.67 97.39 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -158.65 128.46 5.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.28 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' H ' HG13 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 108' ' ' ILE . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.647 ' HD1' HD13 ' A' ' 38' ' ' LEU . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -133.78 138.93 32.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 22' ' ' ILE . 1.9 Cg_endo -42.69 173.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.792 2.328 . . . . 0.0 112.37 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.26 106.21 0.98 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.31 2.006 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.37 176.16 2.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.2 44.84 2.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.804 0.335 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 m -129.82 73.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 22' ' ' ILE . 6.7 m-20 -121.0 108.68 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -129.11 142.45 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.98 12.44 59.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.669 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.76 110.92 10.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.72 66.42 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.826 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.826 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 38' ' ' LEU . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.614 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD11 ' HE2' ' A' ' 119' ' ' PHE . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.028 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.729 HD12 HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.685 HG22 HH22 ' A' ' 48' ' ' ARG . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.61 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.627 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 70' ' ' ALA . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 3.3 pm0 -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.819 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.731 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HG21 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 85' ' ' VAL . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.587 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.847 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.698 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 18' ' ' SER . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.557 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CD2' HG21 ' A' ' 17' ' ' VAL . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.42 82.93 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 130' ' ' VAL . 15.7 t -150.91 25.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -87.98 -43.23 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.82 134.71 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.919 0.39 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.91 176.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.301 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.14 166.9 28.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 5' ' ' LEU . 7.0 pt-20 -149.05 131.52 15.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -140.05 119.22 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.7 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.49 90.77 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.91 -171.81 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.56 103.83 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.431 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 50' ' ' THR . 26.5 t -157.44 123.02 4.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.151 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.678 ' HE2' HD12 ' A' ' 38' ' ' LEU . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.993 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 21' ' ' ARG . 5.9 mm -112.24 81.46 3.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.694 ' HD3' ' HG3' ' A' ' 21' ' ' ARG . 1.7 Cg_endo -43.88 140.23 5.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.82 2.347 . . . . 0.0 112.507 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.99 100.46 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.49 2.127 . . . . 0.0 112.09 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.658 ' NH1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -148.12 -74.87 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' NH1' ' A' ' 25' ' ' ARG . . . -137.78 94.47 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.17 112.99 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.39 -88.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.353 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -167.78 -37.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.853 0.359 . . . . 0.0 110.66 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.7 142.4 15.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.144 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 36' ' ' TRP . 8.2 t80 -166.63 -165.83 0.79 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.907 -0.172 . . . . 0.0 110.698 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.54 139.01 20.49 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.905 HD11 ' HD2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 38' ' ' LEU . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.715 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.915 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.889 HD11 HG22 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.616 ' CD1' HG21 ' A' ' 10' ' ' VAL . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.509 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.95 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.95 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.704 HG21 ' CD1' ' A' ' 96' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 64' ' ' VAL . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.768 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 15.8 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.622 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 76' ' ' GLN . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.758 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.691 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.691 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 94' ' ' ILE . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.637 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.48 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.731 HG22 HG13 ' A' ' 82' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 58' ' ' ILE . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.846 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' HG12 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.586 ' CD1' HD11 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 108' ' ' ILE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' PHE . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -147.35 163.53 36.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.5 t -145.26 -47.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 44.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.641 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.14 91.8 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.017 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.745 179.767 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.665 0.269 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 115.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.834 0.35 . . . . 0.0 111.208 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.78 134.81 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 61.71 3.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.21 -25.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.561 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 7' ' ' TYR . 3.0 mt-10 -146.23 67.3 1.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.371 . . . . 0.0 110.692 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 6' ' ' GLU . 40.9 m-85 -153.98 115.69 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -154.99 134.99 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p -162.7 125.63 2.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 49' ' ' ILE . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.591 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.686 ' CD2' HD23 ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -124.87 113.19 26.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -41.78 -52.62 3.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.737 2.291 . . . . 0.0 112.762 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 37.2 Cg_endo -64.22 108.67 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.128 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -137.01 50.05 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.88 35.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -147.85 179.23 7.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.971 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -130.71 83.92 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.64 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.22 -172.43 13.64 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 3.9 t80 -166.76 142.05 4.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -65.51 157.24 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.903 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.678 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.715 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.861 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.654 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 54' ' ' LYS . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.681 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.747 HG22 HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.726 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' OD1' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.726 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 3.0 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.726 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 89' ' ' SER . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.783 ' O ' HG11 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.736 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.59 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HB2' ' NH2' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.534 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.739 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.635 HG22 HG13 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.752 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.51 130.75 36.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.5 t -150.5 -54.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -88.25 52.95 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -83.09 81.94 8.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.81 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.99 107.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.186 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 98.97 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -152.03 174.44 13.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.78 63.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 110.712 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -152.35 66.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 -178.77 6.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.99 100.15 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.49 121.93 3.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 49' ' ' ILE . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 48' ' ' ARG . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.793 HG22 HG12 ' A' ' 108' ' ' ILE . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 38' ' ' LEU . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' HE1' ' A' ' 105' ' ' PHE . 1.3 mp -114.76 74.05 3.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.85 117.74 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 112.585 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 162.18 41.0 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.464 2.109 . . . . 0.0 112.213 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -131.0 -70.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.94 67.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.188 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -165.0 161.43 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.71 -65.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.743 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 140.85 45.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.12 146.89 18.45 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.25 117.3 14.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.896 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.501 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -61.03 147.08 44.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.006 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 20' ' ' TYR . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.753 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.55 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.001 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.658 ' CD1' HG21 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 76' ' ' GLN . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 1.001 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' OD1' ' A' ' 62' ' ' ASP . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.758 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.707 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.71 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.006 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.693 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.847 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.749 HG12 HD12 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.617 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.585 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.758 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 107' ' ' GLY . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 106' ' ' ILE . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.793 HG12 HG22 ' A' ' 19' ' ' VAL . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.656 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.656 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.63 HG21 ' CE2' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.547 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -91.12 125.4 35.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.5 t -149.52 -46.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -87.99 61.45 6.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.316 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.49 85.43 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.74 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.772 -179.776 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.666 0.27 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.6 -55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 111.132 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.13 45.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.515 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -149.21 10.91 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 5' ' ' LEU . 1.7 tp -150.29 75.03 1.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 110.155 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.5 105.32 5.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -80.95 128.41 33.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.876 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 83.92 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.683 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -158.18 127.49 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.968 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG23 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.729 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 18' ' ' SER . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.765 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.91 82.86 16.96 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 3.1 Cg_exo -42.18 -53.52 3.54 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.686 2.258 . . . . 0.0 112.794 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 41.4 Cg_endo -67.15 -166.19 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.299 2.0 . . . . 0.0 112.075 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -173.61 75.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.583 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' HH2' ' A' ' 36' ' ' TRP . . . -78.95 27.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 130.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -46.05 -33.86 3.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.282 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -146.35 154.32 41.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.94 150.45 51.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.519 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CE1' HG21 ' A' ' 86' ' ' THR . 0.6 OUTLIER -167.13 127.37 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 69.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.561 ' HH2' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.699 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB2' HG12 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.615 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.778 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 2.0 pt20 -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.745 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.72 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.72 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.631 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.566 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.723 HG21 ' CE1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.918 ' HB3' HG11 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.628 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.824 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.727 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.956 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.598 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' A' ' 80' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.745 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.463 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 108' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 106' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 121' ' ' VAL . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 2.3 t-20 -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.475 HG11 ' CE1' ' A' ' 117' ' ' PHE . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 -146.01 57.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.6 t -145.63 23.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -88.94 -21.38 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -160.03 139.93 11.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.998 179.865 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.724 0.297 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.79 -176.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.54 80.28 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -143.72 -8.99 0.72 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.702 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -88.09 74.42 8.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.31 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 7.4 mt-10 -148.0 97.97 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -159.71 -165.27 1.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.775 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.6 77.95 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -157.58 125.68 5.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.883 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 49' ' ' ILE . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.625 HG11 ' NH1' ' A' ' 48' ' ' ARG . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' VAL . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' CZ3' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.512 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -111.49 116.48 50.56 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.632 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 35.3 Cg_endo -67.09 -29.67 39.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.379 2.053 . . . . 0.0 113.435 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HB2' ' CG ' ' A' ' 29' ' ' ARG . 55.9 Cg_endo -71.9 108.79 2.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.664 1.576 . . . . 0.0 112.263 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -126.77 71.55 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.995 0.426 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.59 178.05 7.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.06 -65.92 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.957 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -83.15 55.91 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.372 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.673 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -131.24 13.27 5.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.06 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.33 144.74 15.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.353 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.14 143.89 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.891 0.377 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 16.7 mmt-85 -67.67 163.74 20.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB2' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.847 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.625 ' NH1' HG11 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.792 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 75' ' ' GLU . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.748 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.748 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.703 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 55' ' ' ILE . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.803 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' H ' ' A' ' 89' ' ' SER . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.597 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.727 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.661 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.528 ' CB ' HG13 ' A' ' 74' ' ' VAL . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.621 ' C ' HG23 ' A' ' 100' ' ' THR . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.661 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 12' ' ' CYS . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.527 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.481 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.527 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -153.68 91.06 1.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.4 t -153.57 -54.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -93.1 35.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.94 113.82 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.837 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.894 0.378 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.92 86.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.314 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.24 62.12 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.37 146.77 25.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.22 55.19 2.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -152.85 84.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.21 85.2 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.09 136.8 9.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -162.84 172.04 15.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.676 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.863 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.649 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' CG1' ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 22' ' ' ILE . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.693 ' C ' HD13 ' A' ' 22' ' ' ILE . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.71 HD11 ' CE2' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -113.47 94.49 32.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.1 Cg_endo -42.92 -47.7 8.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.746 2.297 . . . . 0.0 112.507 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 37.0 Cg_endo -65.19 156.71 61.5 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.009 1.806 . . . . 0.0 112.13 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -96.34 143.67 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.25 86.45 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -57.06 -50.27 73.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.039 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -84.77 -73.38 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HD2' ' OE1' ' A' ' 83' ' ' GLU . 8.7 ttp180 -161.3 178.5 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.0 -85.87 0.81 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 3.2 m-85 -166.0 149.11 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.827 0.346 . . . . 0.0 110.383 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HB2' ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.63 161.38 14.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CZ3' ' HB2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.551 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.875 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 12' ' ' CYS . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 56' ' ' ALA . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' C ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.642 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.013 HG11 HG21 ' A' ' 96' ' ' ILE . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.761 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.903 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 97' ' ' GLN . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.682 ' C ' ' HD3' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HD2' ' A' ' 29' ' ' ARG . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG12 ' OH ' ' A' ' 20' ' ' TYR . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.614 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.013 HG21 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.649 ' HB2' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 102' ' ' ARG . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.903 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.584 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.666 ' HA3' ' CE2' ' A' ' 20' ' ' TYR . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 94' ' ' ILE . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.52 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.52 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 117' ' ' PHE . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' HB2' HG13 ' A' ' 10' ' ' VAL . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.44 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -88.29 130.49 35.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.57 -62.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -149.23 -169.59 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 8.3 mt-30 -150.71 107.36 3.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.904 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.717 HG12 ' HB2' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.618 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.618 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.803 ' CD2' HD23 ' A' ' 38' ' ' LEU . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.632 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.93 0.395 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 87' ' ' ASP . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.825 ' CZ2' HD13 ' A' ' 38' ' ' LEU . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.825 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HG2' HD21 ' A' ' 38' ' ' LEU . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.68 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' VAL . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HD3' ' HD2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 58' ' ' ILE . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.779 ' HD3' HD11 ' A' ' 55' ' ' ILE . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.779 HD11 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.689 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 60' ' ' LEU . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.805 ' HB1' ' NE ' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 89' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.675 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.675 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.654 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.661 HG12 ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.805 ' NE ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 74' ' ' VAL . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 100' ' ' THR . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.609 HH12 ' HB2' ' A' ' 104' ' ' ALA . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB2' HH12 ' A' ' 102' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.661 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.654 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.547 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 121' ' ' VAL . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 122' ' ' SER . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 117' ' ' PHE . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.4 m0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.628 0.251 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 49' ' ' ILE . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.537 ' HB3' HG12 ' A' ' 49' ' ' ILE . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.757 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.755 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.645 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.608 ' CD2' HD11 ' A' ' 38' ' ' LEU . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.107 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.626 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.626 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.755 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.757 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 10' ' ' VAL . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 75' ' ' GLU . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 51' ' ' SER . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 47' ' ' LEU . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.744 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 1.022 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.631 HG21 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG13 ' A' ' 85' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 1.022 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.617 ' CD1' HG21 ' A' ' 58' ' ' ILE . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.696 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 99' ' ' GLY . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.629 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.808 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 105' ' ' PHE . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.709 HD12 HG12 ' A' ' 94' ' ' ILE . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.593 ' O ' HG22 ' A' ' 121' ' ' VAL . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 117' ' ' PHE . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 25.1 m95 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.57 0.224 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.668 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.573 ' HD2' HD23 ' A' ' 38' ' ' LEU . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HZ2' HD22 ' A' ' 38' ' ' LEU . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 36' ' ' TRP . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.669 HD22 ' HZ2' ' A' ' 36' ' ' TRP . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.686 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.771 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.877 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 10' ' ' VAL . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.697 ' OG ' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.743 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 56' ' ' ALA . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.743 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.643 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HE2' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.637 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.633 ' HZ ' HG12 ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.528 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.613 ' HD1' ' CB ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.988 0.423 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' H ' HG13 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 108' ' ' ILE . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.647 ' HD1' HD13 ' A' ' 38' ' ' LEU . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' OH ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.826 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.826 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 38' ' ' LEU . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.614 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD11 ' HE2' ' A' ' 119' ' ' PHE . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.028 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.729 HD12 HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.685 HG22 HH22 ' A' ' 48' ' ' ARG . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.61 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.627 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 70' ' ' ALA . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.819 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.731 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HG21 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 85' ' ' VAL . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.579 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.587 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.847 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.698 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 18' ' ' SER . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.557 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CD2' HG21 ' A' ' 17' ' ' VAL . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.465 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 50' ' ' THR . 26.5 t . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.069 0.461 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.678 ' HE2' HD12 ' A' ' 38' ' ' LEU . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.993 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 21' ' ' ARG . 5.9 mm . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.905 HD11 ' HD2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 38' ' ' LEU . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.715 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.915 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.889 HD11 HG22 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.616 ' CD1' HG21 ' A' ' 10' ' ' VAL . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.509 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.95 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.95 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.704 HG21 ' CD1' ' A' ' 96' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 64' ' ' VAL . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.768 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 20.4 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.622 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 76' ' ' GLN . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.758 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.691 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.691 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 94' ' ' ILE . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.637 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.48 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.731 HG22 HG13 ' A' ' 82' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 58' ' ' ILE . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.846 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' HG12 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.586 ' CD1' HD11 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 108' ' ' ILE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' PHE . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.851 0.357 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 49' ' ' ILE . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.591 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.686 ' CD2' HD23 ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.042 0.448 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.678 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.588 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.715 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.861 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.654 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 54' ' ' LYS . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.681 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.747 HG22 HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.726 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' OD1' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.726 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 6.7 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.726 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 89' ' ' SER . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.783 ' O ' HG11 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.736 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.59 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HB2' ' NH2' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.534 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.739 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.635 HG22 HG13 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.752 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 49' ' ' ILE . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 48' ' ' ARG . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.793 HG22 HG12 ' A' ' 108' ' ' ILE . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 38' ' ' LEU . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' HE1' ' A' ' 105' ' ' PHE . 1.3 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.501 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.006 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 20' ' ' TYR . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.753 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.55 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.001 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.658 ' CD1' HG21 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 76' ' ' GLN . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.589 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 1.001 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' OD1' ' A' ' 62' ' ' ASP . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.758 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.707 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.71 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.006 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.693 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.847 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.749 HG12 HD12 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.617 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.585 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.758 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 107' ' ' GLY . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 106' ' ' ILE . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.793 HG12 HG22 ' A' ' 19' ' ' VAL . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.656 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.656 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.63 HG21 ' CE2' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 110.968 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG23 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.729 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 18' ' ' SER . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.765 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.621 ' N ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.699 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB2' HG12 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.615 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.778 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.745 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.72 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.72 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.631 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.566 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.621 ' HG1' ' N ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.918 ' HB3' HG11 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.628 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.824 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.727 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.956 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.598 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' A' ' 80' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.745 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.463 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 108' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 106' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 121' ' ' VAL . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.475 HG11 ' CE1' ' A' ' 117' ' ' PHE . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.436 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.7 m-70 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 49' ' ' ILE . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.625 HG11 ' NH1' ' A' ' 48' ' ' ARG . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' VAL . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' CZ3' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.512 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 16.7 mmt-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.993 0.425 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB2' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.847 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.625 ' NH1' HG11 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.792 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 75' ' ' GLU . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.748 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.748 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.703 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 55' ' ' ILE . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.803 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' H ' ' A' ' 89' ' ' SER . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.597 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.727 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.661 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.634 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.528 ' CB ' HG13 ' A' ' 74' ' ' VAL . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.621 ' C ' HG23 ' A' ' 100' ' ' THR . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.661 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 12' ' ' CYS . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.527 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.481 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.527 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.732 0.301 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.676 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.863 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.649 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' CG1' ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 22' ' ' ILE . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.693 ' C ' HD13 ' A' ' 22' ' ' ILE . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.71 HD11 ' CE2' ' A' ' 20' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HB2' ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.331 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.518 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.551 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.875 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 12' ' ' CYS . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 56' ' ' ALA . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' C ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.642 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 2.6 mp0 -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.013 HG11 HG21 ' A' ' 96' ' ' ILE . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.761 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.903 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 97' ' ' GLN . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.682 ' C ' ' HD3' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG12 ' OH ' ' A' ' 20' ' ' TYR . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.614 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.013 HG21 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.649 ' HB2' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 102' ' ' ARG . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.903 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.584 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.666 ' HA3' ' CE2' ' A' ' 20' ' ' TYR . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 94' ' ' ILE . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.52 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.52 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 117' ' ' PHE . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' HB2' HG13 ' A' ' 10' ' ' VAL . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.44 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.771 0.32 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.05 -36.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 111.087 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.89 117.99 22.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.211 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -36.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.752 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 5' ' ' LEU . 3.8 pp -150.13 128.62 12.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' O ' ' HD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -86.63 147.67 25.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.51 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.517 ' HD1' ' O ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -152.2 170.93 18.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 110.685 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.54 89.39 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 29.2 t -159.16 120.96 3.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.218 0.532 . . . . 0.0 110.912 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 49' ' ' ILE . 35.6 m -58.22 -45.26 88.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.304 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 66.45 38.24 4.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.576 ' HB2' HG12 ' A' ' 49' ' ' ILE . 3.0 m -82.72 138.08 34.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.576 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.717 HG12 ' HB2' ' A' ' 48' ' ' ARG . 22.7 m -151.11 170.07 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.131 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.618 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -172.53 104.75 0.34 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 120.966 0.412 . . . . 0.0 111.601 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 52.8 Cg_endo -64.84 -25.17 60.53 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.184 2.589 . . . . 0.0 113.417 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.618 ' H ' ' HE2' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -125.91 101.51 6.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.8 0.333 . . . . 0.0 111.038 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 47' ' ' LEU . 9.0 p -152.01 155.1 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.7 m -124.25 142.91 50.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.998 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 3.5 p -142.32 149.4 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.189 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.803 ' CD2' HD23 ' A' ' 38' ' ' LEU . 12.7 m-85 -105.42 159.01 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.435 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -121.96 118.46 28.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.598 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.632 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -135.31 137.87 27.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.002 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.08 131.78 4.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.704 2.269 . . . . 0.0 112.244 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.91 78.76 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.382 2.054 . . . . 0.0 111.368 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.74 150.72 50.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.248 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.64 117.35 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.532 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.3 m -106.42 15.5 25.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.002 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -166.47 -160.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.596 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -116.22 -49.82 2.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.24 124.25 9.88 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.73 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.6 -176.61 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.62 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -161.48 64.0 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.503 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -57.96 -50.24 74.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.012 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 87' ' ' ASP . 16.4 m -47.07 -30.07 2.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.63 -21.11 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.171 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.825 ' CZ2' HD13 ' A' ' 38' ' ' LEU . 18.0 t90 -77.82 -51.32 10.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.821 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 6.0 tppt? 59.86 156.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.94 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.825 HD13 ' CZ2' ' A' ' 36' ' ' TRP . 3.4 tp -179.29 118.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 -8.0 3.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.752 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 1.7 tm0? -91.08 -69.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HG2' HD21 ' A' ' 38' ' ' LEU . 38.1 Cg_endo -69.04 98.79 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 121.229 1.286 . . . . 0.0 111.471 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.68 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -166.07 73.69 0.18 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.638 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.67 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.9 p-90 -73.07 161.38 30.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.769 0.318 . . . . 0.0 110.678 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 17' ' ' VAL . . . 179.48 -158.68 22.74 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.715 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HD3' ' HD2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -101.54 136.1 41.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 110.765 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -130.06 141.17 50.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.31 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -158.36 162.4 37.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.605 ' CG2' HG22 ' A' ' 58' ' ' ILE . 7.0 pt -136.9 153.12 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.61 169.14 24.42 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.346 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 88.0 p -142.91 124.5 14.89 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.539 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.779 ' HD3' HD11 ' A' ' 55' ' ' ILE . 2.4 mtpm? -60.04 -56.01 26.89 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.888 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.39 -63.02 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.789 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -21.5 21.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.572 0.225 . . . . 0.0 111.259 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.779 HD11 ' HD3' ' A' ' 52' ' ' LYS . 2.7 pp -134.41 -176.79 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.059 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 74' ' ' VAL . . . -142.42 165.05 28.48 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.097 0.475 . . . . 0.0 111.549 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.689 ' HE1' ' HG3' ' A' ' 52' ' ' LYS . 42.2 p90 -156.78 139.51 15.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.651 HD12 HD23 ' A' ' 60' ' ' LEU . 1.9 pp -99.62 126.79 52.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.531 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 8.9 mtmt -108.87 143.11 38.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 0.0 110.589 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -145.12 154.47 42.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.84 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.86 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.55 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -166.64 128.51 1.76 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 21.6 tptt -62.17 -22.44 65.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.86 -57.71 4.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.711 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.25 -41.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.572 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 -138.41 34.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.63 -77.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.562 0.22 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.2 mt -48.25 -69.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 81.67 133.67 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.952 0.406 . . . . 0.0 110.99 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' HD1' ' A' ' 69' ' ' PHE . . . -165.54 172.79 11.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.738 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 4.5 pm0 -162.73 169.58 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.789 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -131.91 98.66 17.34 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.3 Cg_endo -65.67 141.23 65.46 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.559 2.173 . . . . 0.0 112.358 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 2.5 m -124.63 147.65 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -73.4 -11.91 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.443 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 64.64 48.04 2.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.176 0.513 . . . . 0.0 110.23 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.4 t80 -157.26 -59.7 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.908 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 66.1 Cg_endo -73.23 50.14 1.82 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.747 1.631 . . . . 0.0 112.357 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.83 111.67 4.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.743 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.1 pp -172.78 -175.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.858 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.805 ' HB1' ' NE ' ' A' ' 95' ' ' ARG . . . 73.03 71.43 0.13 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.575 0.702 . . . . 0.0 111.119 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.2 t -149.32 125.71 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.223 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -160.02 175.98 12.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.077 0.465 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -128.44 -158.66 0.9 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.339 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.617 HG21 ' H ' ' A' ' 89' ' ' SER . 7.0 m -74.32 107.83 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.858 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.9 p -61.22 -36.62 80.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.898 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -99.5 4.52 46.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.7 m 70.63 115.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.636 0.255 . . . . 0.0 111.076 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.675 ' O ' ' HD2' ' A' ' 90' ' ' ARG . 2.1 m -135.48 -83.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.777 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.675 ' HD2' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 175.14 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -167.41 -172.62 2.0 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.389 -0.194 . . . . 0.0 110.707 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.654 ' CE2' ' HB ' ' A' ' 108' ' ' ILE . 21.3 p90 -151.63 162.99 40.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.817 0.341 . . . . 0.0 111.599 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.661 HG12 ' HA2' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -129.05 151.54 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.353 179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -143.24 146.96 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.994 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.805 ' NE ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -142.76 172.8 12.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.122 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 74' ' ' VAL . 5.8 mt -143.11 169.79 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.779 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.611 ' OE1' ' HA ' ' A' ' 100' ' ' THR . 16.1 tt0 -146.57 158.63 43.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 111.262 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -153.68 126.6 8.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 111.58 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 83.28 -12.64 49.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.142 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 2.7 m 82.71 46.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.155 0.502 . . . . 0.0 109.809 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.45 -27.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.211 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.609 HH12 ' HB2' ' A' ' 104' ' ' ALA . 0.4 OUTLIER -109.59 116.2 31.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.017 0.408 . . . . 0.0 110.766 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -144.49 136.87 26.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.257 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.609 ' HB2' HH12 ' A' ' 102' ' ' ARG . . . -110.85 136.84 49.28 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.385 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 6.7 t80 -108.69 128.07 54.54 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 108' ' ' ILE . 2.6 pt -146.66 158.4 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.661 ' HA2' HG12 ' A' ' 93' ' ' VAL . . . -106.95 147.03 16.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.247 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.654 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 17.3 mm -131.79 132.37 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.797 0.332 . . . . 0.0 110.79 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -168.26 -179.15 40.51 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.351 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -150.1 168.75 23.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.737 0.303 . . . . 0.0 110.362 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 t -61.82 -8.32 4.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.433 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -145.84 150.88 36.99 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -35.16 42.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.97 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.61 -51.75 46.32 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.823 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.48 -49.87 56.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.82 0.343 . . . . 0.0 110.929 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.547 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -54.26 -22.66 12.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 121' ' ' VAL . 17.3 t80 -75.58 -54.78 6.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.552 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 122' ' ' SER . 11.0 m-20 -51.42 -42.04 61.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.241 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -61.52 -56.33 21.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.877 0.37 . . . . 0.0 110.306 179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 123' ' ' LEU . 4.6 m-20 -55.74 -55.48 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.588 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 117' ' ' PHE . 27.4 m -58.26 -24.36 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.568 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -68.44 -51.69 40.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.943 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 120' ' ' ASN . 3.0 pp -57.26 -36.41 70.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.788 0.328 . . . . 0.0 110.769 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -67.36 -50.95 57.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -42.98 -40.72 3.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.301 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.497 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 8.2 m80 -75.22 -38.79 60.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.05 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -68.36 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.618 ' HE3' HG21 ' A' ' 130' ' ' VAL . 7.1 pttt -84.06 150.34 25.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -91.34 122.11 33.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.994 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.618 HG21 ' HE3' ' A' ' 128' ' ' LYS . 16.3 t -148.58 -62.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -31.87 19.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.218 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -156.85 -172.0 3.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.842 0.353 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.65 167.18 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.054 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.45 -64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.327 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -147.61 142.59 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 6' ' ' GLU . 2.4 tp -153.33 -176.6 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -86.84 105.58 17.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.02 0.438 . . . . 0.0 110.63 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.5 96.34 4.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -76.24 164.84 25.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.803 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HB2' ' H ' ' A' ' 51' ' ' SER . 9.3 p -77.99 146.6 35.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.736 HG11 HD11 ' A' ' 49' ' ' ILE . 4.5 t -53.58 -47.37 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER 71.62 28.99 2.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.978 0.418 . . . . 0.0 111.376 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.537 ' HB3' HG12 ' A' ' 49' ' ' ILE . 13.6 t -82.02 135.95 35.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.757 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 3.8 m -151.29 162.31 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.009 0.433 . . . . 0.0 111.508 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.15 97.21 0.31 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.037 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.755 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 55.8 Cg_endo -71.27 -22.72 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.387 2.058 . . . . 0.0 112.648 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.21 94.41 5.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.404 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' ' HE1' ' A' ' 110' ' ' PHE . 10.1 p -156.67 154.74 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.014 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -115.47 129.06 56.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.697 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.645 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -108.59 -179.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.791 0.329 . . . . 0.0 111.176 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.608 ' CD2' HD11 ' A' ' 38' ' ' LEU . 78.2 m-85 -149.72 154.54 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -125.41 109.54 12.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG12 ' HZ2' ' A' ' 36' ' ' TRP . 11.1 mt -117.34 112.98 39.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.266 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 22' ' ' ILE . 1.7 Cg_endo -44.5 127.44 7.62 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.601 2.201 . . . . 0.0 112.121 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.73 171.74 11.65 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.421 2.081 . . . . 0.0 112.252 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -172.06 -69.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -137.85 160.99 37.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -86.45 60.05 6.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -69.53 141.26 53.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -98.55 -52.59 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HG2' ' A' ' 29' ' ' ARG . . . -75.37 94.84 0.94 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.753 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -73.21 -178.37 2.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 0.0 111.2 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.6 74.45 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.777 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -62.7 -48.37 79.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.879 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -48.11 -28.67 3.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.52 -21.0 13.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.962 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.626 ' CH2' HD13 ' A' ' 38' ' ' LEU . 22.8 t90 -85.53 -12.02 52.72 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.603 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 68.53 -106.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.501 -0.285 . . . . 0.0 111.042 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.626 HD13 ' CH2' ' A' ' 36' ' ' TRP . 30.0 tp 138.91 43.02 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.594 0.757 . . . . 0.0 110.208 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -85.46 38.75 0.75 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.25 0.548 . . . . 0.0 110.076 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.763 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.5 mp0 -79.43 -175.96 0.65 Allowed Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.18 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.763 ' HD2' ' HB3' ' A' ' 40' ' ' GLN . 17.7 Cg_endo -58.63 -62.97 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.917 1.745 . . . . 0.0 113.174 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 51.8 t0 76.07 62.11 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.956 0.407 . . . . 0.0 110.849 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.9 p-90 -79.13 160.47 27.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.622 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -117.28 132.42 56.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.449 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 63' ' ' LYS . . . -175.73 -171.21 39.41 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.879 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.755 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 14.4 ptm180 -102.21 135.25 44.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 110.961 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -121.87 143.3 49.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.494 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.757 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -163.52 167.97 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.22 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.736 HD11 HG11 ' A' ' 10' ' ' VAL . 2.0 pt -141.02 149.32 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.804 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.32 164.5 36.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.836 0.35 . . . . 0.0 111.445 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.9 p -146.99 133.12 19.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.766 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -56.78 11.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.307 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.56 -66.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.233 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.35 -22.38 26.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.655 0.264 . . . . 0.0 110.947 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 75' ' ' GLU . 1.4 pt -127.77 -175.96 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 111.802 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 51' ' ' SER . . . -149.28 163.15 38.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.002 0.43 . . . . 0.0 111.681 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -156.23 140.63 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.024 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.617 HG21 ' CD1' ' A' ' 96' ' ' ILE . 1.6 pp -100.5 141.07 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.428 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' O ' HD23 ' A' ' 60' ' ' LEU . 2.4 mtpp -122.99 137.71 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 47' ' ' LEU . 3.1 mt -126.35 154.95 42.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.828 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -166.72 172.63 10.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.996 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.75 152.81 44.2 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.972 0.415 . . . . 0.0 111.141 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 9.2 ttmt -66.06 -19.6 65.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.566 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 65' ' ' SER . 47.4 t -83.83 -20.17 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.279 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 5.7 t 93.88 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.751 0.421 . . . . 0.0 111.179 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 114.71 114.02 3.01 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.268 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.6 tt0 176.62 -139.67 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.136 0.174 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 69' ' ' PHE . 7.4 tt -43.6 -54.06 5.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.618 0.247 . . . . 0.0 111.508 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 68' ' ' LEU . 54.2 t80 67.27 121.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.37 . . . . 0.0 110.751 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . . . -131.3 139.38 49.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.197 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.37 150.04 50.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 0.0 111.281 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -144.1 76.48 15.03 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 45.0 Cg_endo -67.97 141.29 52.89 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.696 2.264 . . . . 0.0 112.686 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 98' ' ' ASP . 33.7 m -139.39 166.71 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.582 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.564 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.7 tt0 -84.13 -1.17 54.51 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.107 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 51.24 89.07 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.015 0.436 . . . . 0.0 111.414 -179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.744 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 1.5 t80 -163.93 -61.64 0.01 OUTLIER Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.459 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 82.7 Cg_endo -74.12 56.51 3.74 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.291 1.994 . . . . 0.0 112.286 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.775 ' O ' HG23 ' A' ' 80' ' ' ILE . . . -68.22 103.74 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.213 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 79' ' ' GLY . 1.8 pp -170.9 -176.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 122.493 0.317 . . . . 0.0 110.27 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 1.022 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 80.67 68.52 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.225 0.536 . . . . 0.0 110.645 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.2 m -149.87 122.26 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.549 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.17 178.45 10.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.465 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.6 p -121.13 -169.17 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.933 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.631 HG21 ' H ' ' A' ' 89' ' ' SER . 2.5 m -70.07 121.62 20.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.183 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.7 m -63.77 -37.79 88.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' SER . 0.1 OUTLIER -96.52 4.01 52.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 85' ' ' VAL . 57.8 m 64.62 125.4 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.579 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.631 ' H ' HG21 ' A' ' 85' ' ' VAL . 22.8 t -179.28 61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.36 43.84 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG13 ' A' ' 85' ' ' VAL . 19.3 t80 -147.58 159.13 44.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.475 ' CZ ' ' CE1' ' A' ' 119' ' ' PHE . 17.3 p90 -151.1 165.8 32.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.7 0.285 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.5 m -130.12 142.33 44.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.889 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.709 HG12 HD12 ' A' ' 108' ' ' ILE . 1.8 pp -143.99 156.93 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.336 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 1.022 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -154.33 -179.17 7.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.617 ' CD1' HG21 ' A' ' 58' ' ' ILE . 31.2 mt -139.32 164.5 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.153 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.696 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -135.09 167.97 19.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.569 0.223 . . . . 0.0 111.283 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.521 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 14.1 t0 -169.46 133.5 1.34 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.233 0.539 . . . . 0.0 111.979 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.598 ' O ' HG22 ' A' ' 100' ' ' THR . . . 74.69 -15.31 3.82 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.424 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 99' ' ' GLY . 0.5 OUTLIER 90.68 20.54 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.949 0.499 . . . . 0.0 110.383 -178.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.43 8.76 0.09 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.81 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -134.51 114.21 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.324 0.562 . . . . 0.0 110.128 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.629 ' HB3' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -142.93 138.41 30.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -111.48 132.01 54.8 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.808 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.9 t80 -108.62 138.51 44.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.787 0.327 . . . . 0.0 110.432 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.808 HD13 ' O ' ' A' ' 105' ' ' PHE . 3.8 mm -143.52 163.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.79 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -114.97 137.0 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.388 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.709 HD12 HG12 ' A' ' 94' ' ' ILE . 18.9 mt -134.86 145.35 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.704 0.287 . . . . 0.0 110.923 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -172.86 37.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.729 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 17' ' ' VAL . 70.2 m-85 -152.95 148.55 27.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.005 0.431 . . . . 0.0 111.25 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 p -61.36 -9.86 6.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.194 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.37 177.94 9.77 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-O 120.863 0.363 . . . . 0.0 110.615 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.95 10.36 19.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.112 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.01 -69.2 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -55.91 -42.68 76.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.404 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -48.54 -61.19 2.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.297 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.593 ' O ' HG22 ' A' ' 121' ' ' VAL . 25.3 t80 -46.73 -63.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.939 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -44.41 67.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.408 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.475 ' CE1' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -62.29 -46.83 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -66.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.555 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 117' ' ' PHE . 2.9 m -46.39 -31.75 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.684 0.278 . . . . 0.0 111.737 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -69.23 -54.48 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.882 0.372 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 24.0 tp -54.98 -33.5 62.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.777 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -55.23 7.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.173 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -50.83 -46.37 59.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.036 0.446 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' A' ' 11' ' ' LEU . 17.1 m80 -71.67 -49.49 39.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.001 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.585 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 17.4 t80 -45.65 -70.01 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.734 0.302 . . . . 0.0 111.498 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -88.18 174.48 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.861 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.619 ' CE3' ' HA ' ' A' ' 133' ' ' GLU . 25.1 m95 -86.28 109.03 18.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.1 t -142.46 -46.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.953 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.42 -53.15 4.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -150.94 143.89 24.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.792 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.619 ' HA ' ' CE3' ' A' ' 129' ' ' TRP . 4.4 pm0 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.934 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptm . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.24 30.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.02 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.03 115.92 21.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.619 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' C ' ' HG ' ' A' ' 5' ' ' LEU . 20.7 tt0 -146.14 165.51 28.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.659 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -142.22 93.93 2.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.797 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -149.65 78.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.29 126.95 4.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.627 ' CG ' ' HA2' ' A' ' 53' ' ' GLY . 3.3 pt-20 -153.43 115.54 4.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.469 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.32 138.95 12.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -44.91 -54.71 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.136 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 4.2 tt 80.53 85.11 0.05 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.668 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 51.6 t -153.35 130.29 10.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.33 0.586 . . . . 0.0 111.12 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.877 HG12 ' HB2' ' A' ' 48' ' ' ARG . 33.0 m -150.1 165.62 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.954 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -174.16 96.98 0.31 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 110.503 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -72.82 -21.97 20.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.763 2.308 . . . . 0.0 113.412 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -109.84 85.03 2.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.574 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -149.65 160.55 4.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.99 128.12 51.1 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.571 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -100.13 171.31 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.573 ' HD2' HD23 ' A' ' 38' ' ' LEU . 16.3 m-85 -137.01 151.01 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.213 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 1.5 tpt180 -123.58 116.74 23.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 0.0 111.057 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.8 mt -121.73 66.34 19.92 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.74 0.305 . . . . 0.0 111.202 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -42.99 120.1 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.82 2.346 . . . . 0.0 112.014 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.68 78.1 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.421 2.08 . . . . 0.0 112.188 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.459 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -131.66 46.37 2.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.207 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -133.89 165.63 24.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.556 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.3 43.43 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.894 0.378 . . . . 0.0 110.877 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -159.58 133.98 7.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.52 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -52.23 -42.61 63.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.85 -173.98 37.74 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.206 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.24 131.81 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.818 0.342 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 19.0 ptt-85 -65.15 161.65 18.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.041 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -64.76 -0.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.327 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.424 ' OG ' ' CB ' ' A' ' 87' ' ' ASP . 65.1 m -56.47 -40.76 75.41 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.089 0.471 . . . . 0.0 109.896 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.71 16.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.872 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HZ2' HD22 ' A' ' 38' ' ' LEU . 12.8 t90 -76.71 -60.19 2.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.576 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 36' ' ' TRP . 0.6 OUTLIER 57.38 156.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.669 HD22 ' HZ2' ' A' ' 36' ' ' TRP . 14.7 tp -175.4 123.01 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.82 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -133.95 -6.77 2.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.763 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 16.6 mt-30 -76.14 -61.34 0.85 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.738 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 40' ' ' GLN . 89.9 Cg_endo -70.92 -116.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.872 1.715 . . . . 0.0 112.526 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 65.6 t0 55.07 62.1 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.048 0.452 . . . . 0.0 110.337 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.771 ' CH2' HG21 ' A' ' 19' ' ' VAL . 1.8 p-90 -78.45 160.56 27.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.98 128.03 55.15 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.371 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.72 178.42 47.99 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.468 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 3.8 ptm180 -102.28 147.37 26.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.028 0.442 . . . . 0.0 111.313 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.9 mp -131.43 143.97 50.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.55 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.877 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -159.0 161.14 36.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 111.006 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.836 HD12 HG21 ' A' ' 10' ' ' VAL . 3.7 pt -138.92 152.52 24.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.813 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 163.61 39.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.697 ' OG ' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -144.47 129.23 18.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.237 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.01 -64.31 1.0 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.339 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA2' ' CG ' ' A' ' 8' ' ' GLU . . . -168.07 -63.18 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.879 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.53 -26.88 29.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.319 . . . . 0.0 110.923 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.54 -179.11 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -138.68 146.05 41.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.58 138.09 35.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.682 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 72' ' ' ALA . 2.2 pp -108.64 147.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' ' HB3' ' A' ' 71' ' ' GLN . 6.0 mmtp -128.62 149.45 50.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -133.47 153.31 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.263 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -173.58 174.2 3.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.179 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 46.5 t0 -88.61 133.07 34.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.946 0.403 . . . . 0.0 111.047 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.743 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . 4.8 tmtm? -69.08 -3.6 13.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.994 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.49 -62.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.185 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.59 71.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.722 0.296 . . . . 0.0 111.281 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.17 155.34 4.83 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.371 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 178.75 -156.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.759 0.28 . . . . 0.0 111.144 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -38.3 -59.35 0.89 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.352 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 82.0 t80 69.34 119.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 110.473 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -136.27 137.94 41.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -130.61 143.33 50.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' H ' HG13 ' A' ' 58' ' ' ILE . . . -128.91 89.16 49.67 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.872 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.1 137.24 40.19 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.537 2.158 . . . . 0.0 112.325 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 56' ' ' ALA . 27.5 m -134.16 155.44 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.977 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.548 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -77.63 -0.03 25.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.614 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 58.33 69.64 0.72 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.911 0.386 . . . . 0.0 110.981 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.743 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -159.24 -61.77 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.212 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 71.7 Cg_endo -74.48 58.77 4.61 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.891 1.727 . . . . 0.0 112.52 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -69.25 103.19 1.04 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.066 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -178.69 -161.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 76.83 74.85 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 110.609 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 p -154.42 138.16 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 30.3 mt-10 -148.94 155.11 40.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.6 t -128.06 -167.45 1.76 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.508 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 89' ' ' SER . 6.6 m -72.31 115.23 12.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.363 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -60.71 -39.88 90.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.525 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.424 ' CB ' ' OG ' ' A' ' 34' ' ' SER . 10.1 t70 -97.78 18.17 16.34 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 85' ' ' VAL . 2.9 t 66.63 141.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.643 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.1 m 176.77 177.78 0.26 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.196 0.522 . . . . 0.0 110.953 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 90' ' ' ARG . 0.3 OUTLIER -85.32 34.75 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.848 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 92' ' ' PHE . 7.0 t80 -147.72 164.39 33.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HE2' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -157.16 167.89 29.04 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.039 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 83' ' ' GLU . 2.5 t -125.19 139.88 49.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.491 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -136.21 139.86 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.172 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -147.09 173.26 12.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.208 -178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 103' ' ' SER . 8.2 mt -136.26 157.59 37.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.423 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -125.73 162.5 24.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t0 -168.34 125.4 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.917 0.389 . . . . 0.0 111.802 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 86.2 -15.31 50.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.392 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 99' ' ' GLY . 4.1 m 82.54 36.37 0.06 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.189 0.518 . . . . 0.0 110.031 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.13 -25.17 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.036 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -112.13 120.57 42.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -147.1 143.13 28.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.028 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -109.27 133.03 53.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.225 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.637 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -109.51 148.41 31.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.224 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -162.62 163.09 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.128 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -115.16 152.56 18.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.383 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 94' ' ' ILE . 1.2 pt -146.56 146.55 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 0.0 111.475 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -176.65 -159.68 22.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.867 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.633 ' HZ ' HG12 ' A' ' 17' ' ' VAL . 92.1 m-85 -156.46 159.28 38.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 111.073 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.39 -7.59 10.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.931 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.41 172.55 15.76 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.838 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.33 2.22 41.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.018 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.89 -72.16 0.78 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.491 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -57.04 -32.84 66.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.8 -62.32 1.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.847 0.356 . . . . 0.0 111.123 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 117' ' ' PHE . 7.4 t80 -52.98 -58.19 7.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.006 0.431 . . . . 0.0 110.721 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -54.03 22.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.392 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.528 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -62.48 -36.93 84.03 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.894 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 1.8 t-20 -55.29 -56.18 23.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.457 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.5 m -59.6 -29.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.55 -54.23 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.4 -34.69 66.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.852 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -73.55 -49.81 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.085 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.55 ' OD1' HG11 ' A' ' 130' ' ' VAL . 21.1 m-20 -48.8 -41.36 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.613 ' HD1' ' CB ' ' A' ' 12' ' ' CYS . 8.6 m170 -77.74 -44.89 26.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.101 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.448 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 128' ' ' LYS . 20.6 mtpp -88.38 -175.1 4.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 3.3 p90 -89.38 81.28 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.55 HG11 ' OD1' ' A' ' 125' ' ' ASP . 97.5 t -93.19 -52.25 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.375 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -150.11 -147.21 0.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.675 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.99 120.96 4.72 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.752 0.311 . . . . 0.0 110.615 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.995 -179.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.78 146.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.99 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.26 -5.7 58.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -148.74 110.29 4.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.32 146.64 26.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.984 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -146.4 57.79 1.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -79.59 123.4 27.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -79.67 97.39 6.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 0.0 110.876 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.7 p -158.65 128.46 5.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.28 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.729 HG11 HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -59.21 -40.96 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.519 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 4.2 pp 46.27 31.62 1.28 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' H ' HG13 ' A' ' 10' ' ' VAL . 51.6 m -79.21 144.81 34.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 110.887 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 48' ' ' ARG . 11.0 p -162.94 161.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.46 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -174.37 96.27 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 58.4 Cg_endo -72.23 -20.95 24.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.986 2.457 . . . . 0.0 112.649 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -108.75 87.47 2.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.836 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 ' CD2' ' A' ' 119' ' ' PHE . 1.4 p -167.09 166.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.096 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 108' ' ' ILE . 67.8 m -122.96 134.76 54.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -115.62 150.07 17.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.043 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.647 ' HD1' HD13 ' A' ' 38' ' ' LEU . 32.9 t80 -107.78 141.12 39.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.504 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB3' ' HE1' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -132.6 159.43 39.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.54 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD13 ' OD1' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -133.78 138.93 32.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.336 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD2' ' CG2' ' A' ' 22' ' ' ILE . 1.9 Cg_endo -42.69 173.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.792 2.328 . . . . 0.0 112.37 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.26 106.21 0.98 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.31 2.006 . . . . 0.0 112.26 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.37 176.16 2.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -121.2 44.84 2.42 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.804 0.335 . . . . 0.0 111.121 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.9 m -129.82 73.78 1.55 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 22' ' ' ILE . 6.7 m-20 -121.0 108.68 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -129.11 142.45 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.98 12.44 59.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.669 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -75.76 110.92 10.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.72 66.42 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 91' ' ' TYR . . . -60.28 -41.27 92.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.369 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -54.22 -21.28 8.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.28 -21.57 17.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.479 ' HA ' ' CE3' ' A' ' 36' ' ' TRP . 2.1 t-105 -78.98 -46.58 17.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.849 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 50.96 175.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.784 0.326 . . . . 0.0 111.098 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.826 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.6 OUTLIER 176.69 93.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.738 0.304 . . . . 0.0 111.678 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -90.56 -20.39 22.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.54 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB2' ' HD3' ' A' ' 41' ' ' PRO . 30.9 mt-30 -82.38 -59.65 0.41 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.518 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.826 ' HG2' ' HB2' ' A' ' 38' ' ' LEU . 42.5 Cg_endo -67.42 -144.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.907 1.738 . . . . 0.0 111.906 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 38' ' ' LEU . 7.9 t0 66.03 61.68 0.62 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.128 0.49 . . . . 0.0 110.216 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.614 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -79.77 163.43 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.008 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -109.48 131.52 54.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.571 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.34 179.59 47.31 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.087 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 15' ' ' PRO . 4.4 ttm180 -101.97 123.06 45.23 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD11 ' HE2' ' A' ' 119' ' ' PHE . 1.5 pp -112.4 148.38 34.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.028 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -161.08 164.81 30.51 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.875 0.369 . . . . 0.0 110.75 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.729 HD12 HG11 ' A' ' 10' ' ' VAL . 10.7 pt -153.41 154.96 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.326 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.685 HG22 HH22 ' A' ' 48' ' ' ARG . 12.1 t -163.83 -179.25 6.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 6.8 m -153.2 134.62 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.063 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -60.94 -56.18 24.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.32 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 -12.77 19.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' A' ' 51' ' ' SER . 0.6 OUTLIER -119.63 163.83 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.825 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.61 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -140.25 153.94 46.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.714 0.293 . . . . 0.0 110.828 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 37.5 p90 -160.32 142.33 12.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 111.073 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.627 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.2 pp -102.07 136.71 32.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.79 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HB3' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -122.11 152.76 39.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.301 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 70' ' ' ALA . 1.4 pp -139.27 159.72 41.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' ARG . 5.9 pm0 -177.31 176.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.132 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.608 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 45.3 t0 -80.35 142.62 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.63 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 5.0 tttt -66.58 -1.66 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.841 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.33 -63.19 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.67 0.272 . . . . 0.0 111.093 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.84 72.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.308 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.83 94.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.172 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 9.2 tt0 -80.4 -154.57 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 1.6 pp -40.55 -28.1 0.06 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.719 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER 72.49 128.98 0.04 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -163.89 152.66 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.287 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -160.73 167.58 26.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.534 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.36 9.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 57' ' ' TYR . 36.3 Cg_endo -65.2 136.49 47.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.536 2.158 . . . . 0.0 112.207 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 34.5 m -138.84 140.63 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 121.451 0.643 . . . . 0.0 112.528 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 2.3 mt-10 -70.4 3.11 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.317 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 1.4 pp0? 40.57 96.91 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.819 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -163.8 -70.27 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD2' ' HA ' ' A' ' 98' ' ' ASP . 75.6 Cg_endo -73.82 66.51 4.89 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.483 2.122 . . . . 0.0 112.209 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.22 107.22 1.93 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.97 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' H ' ' A' ' 81' ' ' ALA . 3.6 tp -179.59 -165.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 120.573 0.225 . . . . 0.0 111.07 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.731 ' HB1' ' HD3' ' A' ' 95' ' ' ARG . . . 73.01 80.28 0.14 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.186 0.517 . . . . 0.0 112.148 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 t -148.17 136.86 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.284 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -135.34 144.31 46.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.214 0.53 . . . . 0.0 110.658 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -175.42 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.537 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG21 ' HA ' ' A' ' 88' ' ' SER . 2.5 m -65.63 110.21 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.722 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.5 m -61.43 -15.12 34.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.487 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.26 22.53 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.58 ' HA ' HG21 ' A' ' 85' ' ' VAL . 2.4 t 67.79 134.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.834 0.349 . . . . 0.0 111.638 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.488 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 177.52 50.29 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER 32.73 68.04 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.385 -179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 85' ' ' VAL . 2.3 t80 -171.41 157.1 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.315 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 17.6 p90 -170.14 153.83 4.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.635 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.587 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 11.1 p -132.25 149.99 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.634 0.254 . . . . 0.0 111.336 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -138.38 142.32 35.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.849 0.356 . . . . 0.0 111.388 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.731 ' HD3' ' HB1' ' A' ' 81' ' ' ALA . 54.7 ttt180 -124.45 161.23 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.577 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 46.8 mt -125.75 150.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.179 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -143.31 152.88 42.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.553 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.847 ' HA ' ' HD2' ' A' ' 78' ' ' PRO . 7.9 p-10 -170.13 148.6 3.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 112.221 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.01 -20.05 0.56 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.049 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 98' ' ' ASP . 1.4 m 82.95 42.44 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.1 -24.92 0.02 OUTLIER Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.237 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -117.59 117.2 28.75 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.974 0.387 . . . . 0.0 110.532 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -147.11 132.02 18.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.445 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.64 138.24 47.29 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.455 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.698 ' CD2' ' HD2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -109.68 123.9 50.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 mm -135.38 155.25 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.17 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 93' ' ' VAL . . . -120.02 155.5 16.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.364 -0.922 . . . . 0.0 112.029 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 18' ' ' SER . 4.9 mp -142.6 152.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 110.851 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.557 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . -166.47 -170.66 31.66 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.404 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 115' ' ' ASP . 0.6 OUTLIER -159.13 158.05 32.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.748 0.308 . . . . 0.0 110.625 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.5 m -66.0 0.03 2.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.584 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -149.52 169.88 19.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.772 0.32 . . . . 0.0 110.619 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.27 -41.23 11.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.41 -55.82 10.22 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.759 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.521 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -64.71 -50.78 65.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 0.0 110.679 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -53.54 -25.36 16.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' O ' HG22 ' A' ' 121' ' ' VAL . 43.8 t80 -72.66 -62.87 1.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 121' ' ' VAL . 13.1 m-20 -48.63 -42.65 34.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.355 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' CD2' HG21 ' A' ' 17' ' ' VAL . 2.0 t80 -58.08 -65.16 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.577 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 8.4 t30 -54.04 -52.28 61.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.516 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.9 m -55.53 -29.06 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.646 0.26 . . . . 0.0 111.326 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 14.5 m -68.1 -48.51 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.67 -32.19 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.62 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -49.4 18.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.084 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.69 -44.0 47.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.465 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.1 m-70 -75.18 -50.18 17.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.225 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -55.8 -84.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.827 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 152.41 20.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.351 . . . . 0.0 110.944 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.42 82.93 1.18 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 130' ' ' VAL . 15.7 t -150.91 25.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -87.98 -43.23 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.82 134.71 34.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.129 -0.939 . . . . 0.0 110.843 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.919 0.39 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.91 176.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.301 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.14 166.9 28.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' O ' HD22 ' A' ' 5' ' ' LEU . 7.0 pt-20 -149.05 131.52 15.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -140.05 119.22 12.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.7 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.49 90.77 8.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.615 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.91 -171.81 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.56 103.83 6.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.431 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.509 ' OG ' HG22 ' A' ' 50' ' ' THR . 26.5 t -157.44 123.02 4.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.151 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 49' ' ' ILE . 27.4 m -51.33 -41.61 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.775 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.42 ' HG ' ' CE1' ' A' ' 126' ' ' HIS . 0.2 OUTLIER 58.65 28.91 17.82 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.51 ' HB2' HG12 ' A' ' 49' ' ' ILE . 58.9 m -77.04 144.42 38.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.968 0.413 . . . . 0.0 110.315 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 48' ' ' ARG . 24.8 m -158.25 161.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 14' ' ' LYS . 9.3 tptt -171.71 101.2 0.38 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.479 . . . . 0.0 110.824 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 56.9 Cg_endo -70.93 -26.48 22.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.733 2.288 . . . . 0.0 112.334 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.67 91.29 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.503 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -153.85 156.4 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.226 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 108' ' ' ILE . 35.3 p -119.56 124.03 45.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -99.68 162.91 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.968 0.413 . . . . 0.0 111.775 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.678 ' HE2' HD12 ' A' ' 38' ' ' LEU . 14.5 m-85 -128.23 139.85 52.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.74 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.993 ' HG2' ' HB3' ' A' ' 41' ' ' PRO . 4.6 ptp180 -115.64 139.17 50.37 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 21' ' ' ARG . 5.9 mm -112.24 81.46 3.88 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.674 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.694 ' HD3' ' HG3' ' A' ' 21' ' ' ARG . 1.7 Cg_endo -43.88 140.23 5.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.82 2.347 . . . . 0.0 112.507 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.99 100.46 0.52 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.49 2.127 . . . . 0.0 112.09 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.658 ' NH1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -148.12 -74.87 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' NH1' ' A' ' 25' ' ' ARG . . . -137.78 94.47 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.17 112.99 4.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.806 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.39 -88.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.353 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -167.78 -37.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.853 0.359 . . . . 0.0 110.66 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.7 142.4 15.17 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.144 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 36' ' ' TRP . 8.2 t80 -166.63 -165.83 0.79 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.907 -0.172 . . . . 0.0 110.698 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.54 139.01 20.49 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.371 0.605 . . . . 0.0 111.782 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . . . -66.04 1.47 1.45 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.99 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.42 -32.55 74.02 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.087 0.47 . . . . 0.0 110.174 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -140.71 10.08 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.821 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.65 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 9.2 t90 -74.79 -61.04 2.01 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt 54.82 171.95 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.964 0.411 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.905 HD11 ' HD2' ' A' ' 41' ' ' PRO . 2.7 tm? -174.91 133.66 0.34 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.37 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.798 ' N ' HD13 ' A' ' 38' ' ' LEU . 23.3 t0 -154.52 69.34 0.75 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.901 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mm-40 -155.32 -72.89 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HB3' ' HG2' ' A' ' 21' ' ' ARG . 69.2 Cg_endo -66.97 -106.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.498 2.132 . . . . 0.0 112.891 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 42.9 t0 51.48 60.65 3.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.832 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.715 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p-90 -77.93 159.83 28.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.564 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.18 128.34 55.43 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.471 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 63' ' ' LYS . . . -174.95 -178.86 45.14 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.717 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.915 ' HG3' ' HA ' ' A' ' 63' ' ' LYS . 22.0 mtp-105 -99.27 130.57 45.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 110.638 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.889 HD11 HG22 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -121.09 135.56 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.959 0.409 . . . . 0.0 110.65 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -153.98 150.77 28.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.14 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.616 ' CD1' HG21 ' A' ' 10' ' ' VAL . 8.6 pt -129.36 152.3 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.322 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.509 HG22 ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -158.31 175.04 14.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.61 -178.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -150.62 126.93 10.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.18 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.57 -63.56 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.394 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.95 ' HE3' ' HB ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -97.9 -7.05 31.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.318 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.95 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.1 tt -128.34 170.81 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.58 146.25 41.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.184 0.516 . . . . 0.0 110.509 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.09 151.14 28.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.561 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.704 HG21 ' CD1' ' A' ' 96' ' ' ILE . 2.3 pp -105.7 141.46 20.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 143.7 50.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.548 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -129.82 162.83 27.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.123 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.24 172.39 9.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.639 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' HG23 ' A' ' 64' ' ' VAL . 11.7 t70 -72.11 151.48 43.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.915 ' HA ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -61.11 -19.56 61.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.768 ' O ' ' HB2' ' A' ' 65' ' ' SER . 21.2 t -86.09 -17.08 9.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 111.576 0.213 . . . . 0.0 111.576 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.768 ' HB2' ' O ' ' A' ' 64' ' ' VAL . 3.6 m 91.6 87.22 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.115 0.566 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' GLU . . . 113.24 116.76 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.198 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 62' ' ' ASP . 0.3 OUTLIER 178.1 -132.35 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.229 0.212 . . . . 0.0 110.583 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.9 mt -56.85 -61.35 2.5 Favored 'General case' 0 CA--C 1.527 0.083 0 O-C-N 122.378 -0.201 . . . . 0.0 111.366 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.8 t80 76.93 127.4 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 60' ' ' LEU . . . -136.79 147.0 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 20.4 mt-30 -134.56 163.82 28.88 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.622 ' HB3' ' CG1' ' A' ' 58' ' ' ILE . . . -151.91 78.96 6.52 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.454 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.99 142.85 70.22 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.752 2.302 . . . . 0.0 111.848 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 76' ' ' GLN . 20.3 m -141.23 163.58 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.467 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -67.02 -8.74 32.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.607 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.533 ' H ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 56.02 79.12 0.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.758 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -162.74 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.001 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 97' ' ' GLN . 62.7 Cg_endo -71.9 53.44 1.93 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.847 2.365 . . . . 0.0 113.046 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -68.89 104.62 1.28 Allowed Glycine 0 CA--C 1.517 0.211 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.691 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER 178.05 -166.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.694 0.283 . . . . 0.0 111.499 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.691 ' H ' HG13 ' A' ' 80' ' ' ILE . . . 75.73 83.99 0.09 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.757 0.789 . . . . 0.0 111.51 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.731 HG13 HG22 ' A' ' 94' ' ' ILE . 40.9 t -145.77 137.03 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.361 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 1.0 OUTLIER -132.26 149.91 52.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.179 0.514 . . . . 0.0 110.735 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.01 -179.05 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 88' ' ' SER . 1.6 m -68.1 114.62 5.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.097 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 m -61.63 -12.53 16.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.502 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -156.25 26.52 0.36 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER 72.62 135.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.88 0.372 . . . . 0.0 111.71 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -173.66 35.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.637 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 1.1 tpp180 41.45 28.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.48 ' CD2' ' CH2' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -141.86 170.62 15.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CE1' ' CE2' ' A' ' 119' ' ' PHE . 14.2 p90 -165.76 166.14 18.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 105' ' ' PHE . 35.2 m -132.61 146.86 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.731 HG22 HG13 ' A' ' 82' ' ' VAL . 1.4 pt -150.56 152.48 11.47 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 1.4 ptm180 -142.7 176.38 9.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.552 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 58' ' ' ILE . 7.8 mt -131.17 155.42 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.095 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.846 ' HB3' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -122.96 146.95 47.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.894 0.378 . . . . 0.0 111.731 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.517 ' HB2' HG12 ' A' ' 74' ' ' VAL . 68.4 t0 -127.91 81.26 2.01 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.508 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 77.89 4.79 86.16 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.63 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 15.0 m 87.76 -25.77 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.794 0.437 . . . . 0.0 111.434 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.42 -50.87 6.36 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.445 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 3.5 mmt180 -110.53 132.23 54.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.581 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 1.1 m -157.44 141.14 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.107 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -117.28 144.66 44.62 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.89 0.376 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 19.8 t80 -117.64 144.51 45.12 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.586 ' CD1' HD11 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -150.83 161.24 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.495 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -119.55 149.96 17.84 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.402 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 18' ' ' SER . 2.6 mp -143.85 159.04 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.351 . . . . 0.0 110.999 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 108' ' ' ILE . . . -172.98 -166.51 31.56 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.341 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 1.1 m-85 -149.96 160.41 43.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 110.67 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 m -64.1 -12.69 41.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.22 176.07 9.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 0.0 110.553 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.637 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -88.67 -37.34 15.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.144 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.7 -51.67 27.6 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.347 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.463 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 6.8 m-20 -66.03 -49.37 67.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.754 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HA ' ' HD2' ' A' ' 110' ' ' PHE . . . -48.45 -30.8 5.47 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 121' ' ' VAL . 15.6 t80 -70.78 -51.81 24.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.02 -44.22 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.28 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.631 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -63.35 -53.96 44.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 0.5 OUTLIER -54.37 -58.74 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.191 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 117' ' ' PHE . 12.6 m -52.92 -31.65 17.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.353 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -51.09 61.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.869 0.366 . . . . 0.0 110.585 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.844 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.0 -31.27 28.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.487 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -74.47 -51.67 14.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.54 -46.99 28.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.382 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.42 ' CE1' ' HG ' ' A' ' 11' ' ' LEU . 32.9 m170 -77.3 -45.9 24.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.154 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.844 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -59.25 -82.87 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.453 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -90.76 171.7 9.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.864 0.364 . . . . 0.0 110.984 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -147.35 163.53 36.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.784 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.5 t -145.26 -47.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 44.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.641 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.14 91.8 4.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.017 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.745 179.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.665 0.269 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 115.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.834 0.35 . . . . 0.0 111.208 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.78 134.81 6.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.157 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -92.39 61.71 3.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.992 0.425 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.21 -25.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.561 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 7' ' ' TYR . 3.0 mt-10 -146.23 67.3 1.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.371 . . . . 0.0 110.692 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 6' ' ' GLU . 40.9 m-85 -153.98 115.69 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -154.99 134.99 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.804 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.5 p -162.7 125.63 2.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 49' ' ' ILE . 7.3 p -57.2 -36.35 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.448 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 11' ' ' LEU . 4.2 pp 43.33 33.54 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 42.8 t -80.62 145.52 31.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.223 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.654 HG12 ' CB ' ' A' ' 48' ' ' ARG . 15.6 m -153.23 164.39 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.011 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -171.3 90.25 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 111.013 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 60.8 Cg_endo -72.66 -20.63 22.9 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.036 2.491 . . . . 0.0 113.085 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' O ' ' OD2' ' A' ' 115' ' ' ASP . 2.0 p-10 -111.55 88.83 2.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.543 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 10.0 p -161.9 158.75 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.077 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.591 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.41 129.24 56.64 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.324 0.583 . . . . 0.0 110.332 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.861 ' HB ' ' CE2' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.07 153.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.686 ' CD2' HD23 ' A' ' 38' ' ' LEU . 39.7 m-85 -113.07 129.61 56.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.579 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -119.77 146.24 45.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.337 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -124.87 113.19 26.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -41.78 -52.62 3.79 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.737 2.291 . . . . 0.0 112.762 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 37.2 Cg_endo -64.22 108.67 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.128 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -137.01 50.05 2.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.739 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.88 35.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 p -147.85 179.23 7.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.971 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -130.71 83.92 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.64 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.22 -172.43 13.64 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' HB3' ' CE3' ' A' ' 36' ' ' TRP . 3.9 t80 -166.76 142.05 4.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -65.51 157.24 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.903 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.678 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -63.59 -2.82 1.81 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.9 m -56.37 -37.12 69.63 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.0 15.95 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.969 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CE3' ' HB3' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -76.62 -47.22 23.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.616 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 56.36 159.28 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HG ' ' CG ' ' A' ' 41' ' ' PRO . 1.6 tp -174.81 64.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.168 0.508 . . . . 0.0 110.337 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -87.88 -16.56 33.62 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.483 ' N ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.73 -57.32 1.57 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.653 0.263 . . . . 0.0 110.877 -179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.715 ' CG ' ' HG ' ' A' ' 38' ' ' LEU . 44.6 Cg_endo -66.35 -121.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.168 1.912 . . . . 0.0 111.928 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 23.4 t0 55.46 59.19 4.04 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.291 0.496 . . . . 0.0 110.042 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.861 ' CE2' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -77.76 162.87 26.61 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.474 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 t -108.83 125.53 52.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.922 0.392 . . . . 0.0 110.487 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.48 176.19 46.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.556 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 5.6 tmm_? -100.7 131.8 46.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.269 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.24 137.6 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.49 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.654 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -155.71 159.11 39.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.216 -179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 10' ' ' VAL . 8.0 pt -133.67 152.24 34.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.857 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.46 163.9 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.29 132.34 15.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.096 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -59.22 -60.15 4.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.076 0.465 . . . . 0.0 109.797 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.07 -62.55 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -87.48 -34.55 18.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 0.0 110.916 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 54' ' ' LYS . 2.5 pp -111.53 174.49 2.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.175 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.681 ' HB2' ' HG3' ' A' ' 76' ' ' GLN . . . -150.43 162.28 40.88 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.034 0.445 . . . . 0.0 111.33 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.639 ' CB ' ' HA ' ' A' ' 73' ' ' PRO . 1.4 p90 -166.11 150.3 7.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.169 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.747 HG22 HG22 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -107.47 140.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.89 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 71' ' ' GLN . 8.4 mtmm -126.61 147.77 49.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.978 0.418 . . . . 0.0 111.166 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -129.66 162.91 27.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.736 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.38 161.99 1.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.195 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.726 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 62.1 t0 -82.33 128.26 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.947 0.403 . . . . 0.0 110.18 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.61 -1.4 1.25 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' OD1' ' A' ' 62' ' ' ASP . 71.5 t -75.94 -66.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.556 0.217 . . . . 0.0 111.46 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -170.52 59.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 111.34 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.47 93.06 0.04 OUTLIER Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.001 -0.618 . . . . 0.0 113.219 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.726 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.9 tp10 -77.96 -173.31 3.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.81 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 1.2 pp -38.57 -31.62 0.06 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.486 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.9 t80 78.0 126.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.868 0.365 . . . . 0.0 111.153 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -159.43 156.76 28.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.83 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . 6.7 pt20 -162.5 162.54 27.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.736 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.26 95.28 28.02 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.985 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 57' ' ' TYR . 43.8 Cg_endo -67.99 144.03 62.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.274 1.983 . . . . 0.0 113.045 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' HA ' ' OD2' ' A' ' 98' ' ' ASP . 27.7 m -132.79 157.82 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -72.78 -4.07 29.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.483 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER 55.75 77.81 0.22 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 111.33 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.726 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -159.44 -65.64 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.992 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 84.5 Cg_endo -73.83 59.25 4.22 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.397 2.065 . . . . 0.0 112.353 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -67.88 101.26 0.7 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.184 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 1.3 tp 176.77 -178.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 91.49 77.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.142 0.496 . . . . 0.0 110.839 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.0 m -145.64 138.53 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.339 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.618 ' HB3' ' CG2' ' A' ' 93' ' ' VAL . 0.6 OUTLIER -136.05 150.8 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.27 -165.36 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.149 0.499 . . . . 0.0 110.663 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 89' ' ' SER . 22.7 m -66.77 87.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.605 0.717 . . . . 0.0 111.495 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -64.46 -5.07 4.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.396 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -150.67 21.41 0.81 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.049 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.84 121.68 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.15 0.5 . . . . 0.0 112.006 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.783 ' O ' HG11 ' A' ' 85' ' ' VAL . 35.0 t -170.37 149.67 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.122 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.93 30.67 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -149.82 176.11 11.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.314 . . . . 0.0 110.289 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.736 ' CZ ' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -159.55 174.18 15.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.084 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG2' ' HB3' ' A' ' 83' ' ' GLU . 27.4 m -134.34 147.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.622 0.249 . . . . 0.0 110.803 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.518 ' CG2' HD11 ' A' ' 108' ' ' ILE . 1.7 pp -136.54 127.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.813 0.34 . . . . 0.0 111.064 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.651 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 16.0 ttt180 -118.38 156.68 28.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mt -132.15 160.25 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.647 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.9 mt-30 -129.77 149.16 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.038 0.447 . . . . 0.0 110.951 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 18.6 t0 -120.92 94.98 4.52 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.282 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.545 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 54.87 12.49 3.72 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.446 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.59 ' H ' ' HG3' ' A' ' 78' ' ' PRO . 58.0 m 79.73 54.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.163 0.506 . . . . 0.0 109.936 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.14 -27.99 0.02 OUTLIER Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.211 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.747 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -128.88 84.07 2.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 117.12 0.46 . . . . 0.0 110.701 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -112.54 126.05 54.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.412 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.617 ' HB2' ' NH2' ' A' ' 102' ' ' ARG . . . -113.72 139.67 48.89 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.933 0.397 . . . . 0.0 111.844 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.534 ' HE1' ' HB ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -113.86 130.21 56.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.874 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.4 mm -139.02 165.9 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.976 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.739 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -105.98 138.74 14.48 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.218 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.635 HG22 HG13 ' A' ' 19' ' ' VAL . 3.6 pt -138.87 138.88 41.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.828 0.314 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -177.49 -154.45 12.22 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.249 -0.976 . . . . 0.0 113.908 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.692 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 44.8 t80 -163.13 162.65 25.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.025 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.0 p -61.49 -76.16 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.905 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -85.45 -172.77 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.16 3.75 33.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.368 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.41 -71.04 0.85 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.402 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.692 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -49.57 -44.75 47.05 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.669 0.271 . . . . 0.0 111.007 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . -40.53 -60.67 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.971 0.415 . . . . 0.0 110.861 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -54.41 -59.96 3.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.944 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -54.35 -50.58 67.12 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.493 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -61.34 -46.11 91.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.932 0.396 . . . . 0.0 110.299 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 47.4 t30 -58.81 -59.47 5.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 118' ' ' ASP . 34.1 m -50.8 -38.61 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.439 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.93 34.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -52.32 -47.97 65.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.679 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 15.4 pt20 -66.36 -46.45 76.68 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.545 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.533 ' N ' ' HG3' ' A' ' 124' ' ' GLN . 0.5 OUTLIER -53.42 -48.68 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.978 0.418 . . . . 0.0 110.961 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.752 ' HB3' HG23 ' A' ' 10' ' ' VAL . 41.5 m80 -74.73 -45.24 45.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.168 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 2.5 t80 -57.92 -78.17 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.604 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -90.18 166.4 13.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -90.51 130.75 36.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.5 t -150.5 -54.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -88.25 52.95 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -83.09 81.94 8.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.791 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.81 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.841 0.353 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.99 107.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.186 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 98.97 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.035 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -152.03 174.44 13.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.78 63.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 110.712 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -152.35 66.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.804 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.6 -178.77 6.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.99 100.15 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.49 121.93 3.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.837 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.658 HG21 ' CD1' ' A' ' 49' ' ' ILE . 35.7 m -52.45 -39.84 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.843 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 58.44 34.42 23.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 56.1 m -81.44 138.69 35.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.947 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 48' ' ' ARG . 34.1 m -149.64 160.02 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.911 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.87 101.2 0.3 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.841 0.353 . . . . 0.0 110.532 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 55.5 Cg_endo -71.05 -19.48 29.99 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.718 2.278 . . . . 0.0 112.648 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' O ' ' HE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -111.03 94.24 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' CE2' ' A' ' 110' ' ' PHE . 14.5 p -158.76 153.42 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.393 . . . . 0.0 111.329 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.13 130.37 52.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.022 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.793 HG22 HG12 ' A' ' 108' ' ' ILE . 39.0 t -107.49 142.0 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 38' ' ' LEU . 2.6 m-85 -114.6 161.28 18.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.918 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 16.1 ttm180 -125.6 122.75 37.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.643 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.469 HD13 ' HE1' ' A' ' 105' ' ' PHE . 1.3 mp -114.76 74.05 3.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.85 117.74 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.936 2.424 . . . . 0.0 112.585 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.98 162.18 41.0 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.464 2.109 . . . . 0.0 112.213 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -131.0 -70.06 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -176.94 67.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.188 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -165.0 161.43 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -91.71 -65.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.743 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 140.85 45.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.12 146.89 18.45 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.54 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.25 117.3 14.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.397 . . . . 0.0 110.896 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.501 ' HG3' ' HB2' ' A' ' 34' ' ' SER . 0.0 OUTLIER -61.03 147.08 44.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.297 0.57 . . . . 0.0 111.442 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.006 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -65.38 -1.54 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.443 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.82 -36.0 71.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.122 0.487 . . . . 0.0 109.836 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -144.46 10.69 1.45 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.538 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 3.5 t-105 -80.18 -47.23 15.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.727 0.299 . . . . 0.0 110.474 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' H ' ' A' ' 38' ' ' LEU . 1.5 tttm 55.16 168.2 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.678 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 20' ' ' TYR . 6.8 tp -175.65 80.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.915 0.388 . . . . 0.0 111.672 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.55 -22.14 21.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.687 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' CD ' ' A' ' 41' ' ' PRO . 5.2 mp0 -87.0 -72.98 0.06 OUTLIER Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.263 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.753 ' HG2' ' HG ' ' A' ' 38' ' ' LEU . 56.8 Cg_endo -70.5 92.38 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 121.604 1.536 . . . . 0.0 111.621 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 9.0 p-10 -171.34 71.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.368 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.55 ' CZ2' HG11 ' A' ' 19' ' ' VAL . 5.8 p-90 -71.66 162.53 29.31 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.267 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.1 m -114.28 132.07 56.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.48 -172.3 41.85 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.561 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.001 ' HD3' ' HA ' ' A' ' 63' ' ' LYS . 36.4 ptt85 -104.46 141.4 36.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.97 0.415 . . . . 0.0 111.354 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' ARG . 6.6 tt -125.99 139.6 53.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.993 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.84 151.1 29.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.648 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.658 ' CD1' HG21 ' A' ' 10' ' ' VAL . 11.8 pt -135.68 156.11 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -166.19 172.61 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.186 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 p -150.11 133.15 16.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.991 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -58.85 -53.13 61.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.775 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.8 -59.54 0.05 OUTLIER Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.385 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.19 -30.36 13.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.651 0.262 . . . . 0.0 110.888 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 76' ' ' GLN . 11.8 tt -111.54 166.7 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.056 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.589 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -138.39 152.81 48.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.866 0.365 . . . . 0.0 110.966 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -153.25 143.23 22.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.026 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.26 132.86 47.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -114.89 141.22 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 5.9 mt -127.92 151.04 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.183 0.516 . . . . 0.0 110.991 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 66' ' ' GLY . 1.7 tt0 -171.77 164.99 6.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.455 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 54.7 t0 -86.37 138.02 32.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.127 0.489 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 1.001 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -67.73 -5.25 15.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.116 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' OD1' ' A' ' 62' ' ' ASP . 23.7 t -82.89 -67.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 111.11 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 t 178.35 80.31 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.747 0.308 . . . . 0.0 111.503 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' HG3' ' A' ' 61' ' ' GLU . . . 95.69 -100.53 2.54 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.435 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' ASP . 7.3 tp10 78.61 -174.28 0.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.118 0.485 . . . . 0.0 111.272 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 67' ' ' GLU . 6.0 mt -46.63 -49.93 18.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.479 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 86.7 t80 66.7 127.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.031 0.443 . . . . 0.0 111.025 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 60' ' ' LEU . . . -148.85 150.26 32.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.732 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.32 35.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.813 0.34 . . . . 0.0 110.583 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.54 114.05 4.76 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.918 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.51 137.3 46.05 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 98' ' ' ASP . 4.0 t -122.33 142.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.758 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 4.8 mm-40 -68.44 -10.57 56.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.707 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 1.5 tm0? 65.61 134.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.653 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.62 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 0.4 OUTLIER 108.12 -53.94 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 123.785 0.678 . . . . 0.0 111.436 -178.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.71 ' CG ' ' HA ' ' A' ' 98' ' ' ASP . 42.9 Cg_endo -70.46 61.82 2.13 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 121.868 1.712 . . . . 0.0 113.044 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 80' ' ' ILE . . . -79.24 118.22 4.73 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.733 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 81' ' ' ALA . 2.0 tp 179.29 -179.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.583 0.23 . . . . 0.0 110.551 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 81.75 77.31 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.462 0.648 . . . . 0.0 110.72 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -151.27 128.87 2.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.424 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -149.06 163.1 38.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.099 0.476 . . . . 0.0 110.813 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 p -133.04 -161.17 1.11 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.126 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.006 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.9 m -70.15 104.12 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.691 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -8.27 2.9 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.228 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.24 15.72 1.32 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HA ' HG21 ' A' ' 85' ' ' VAL . 6.5 t 76.83 146.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.693 ' HB3' HG11 ' A' ' 85' ' ' VAL . 47.6 t -172.85 -93.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -177.59 32.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.847 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -169.11 -173.25 1.72 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 13.6 p90 -157.96 172.87 17.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.019 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -124.69 133.42 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.749 HG12 HD12 ' A' ' 108' ' ' ILE . 2.6 pp -129.53 131.34 67.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.773 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.849 ' HB3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -131.81 162.58 30.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.617 ' N ' ' HG2' ' A' ' 95' ' ' ARG . 12.6 mt -127.17 156.28 38.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.585 ' HG3' ' N ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -139.74 151.17 45.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.142 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.758 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 2.9 p30 -170.17 152.47 4.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 100' ' ' THR . . . 74.44 -21.09 1.53 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.611 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 25.3 m 84.49 40.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.44 -33.03 0.04 OUTLIER Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.104 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 115.39 29.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.986 0.422 . . . . 0.0 110.963 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -143.6 131.9 22.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.091 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.87 139.84 44.49 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.83 0.348 . . . . 0.0 111.232 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -118.48 140.36 49.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 107' ' ' GLY . 2.4 mm -148.21 167.2 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.488 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 106' ' ' ILE . . . -117.05 145.81 18.74 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.613 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.793 HG12 HG22 ' A' ' 19' ' ' VAL . 49.6 mt -145.64 151.5 14.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.849 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' HA2' ' CE2' ' A' ' 92' ' ' PHE . . . -174.14 -163.03 26.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.901 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.656 ' CG ' ' HB3' ' A' ' 115' ' ' ASP . 96.5 m-85 -153.66 155.57 36.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.4 . . . . 0.0 110.698 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -4.1 5.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.454 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.17 143.22 28.06 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 110.772 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -37.75 75.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -45.3 -55.5 6.68 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.809 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.656 ' HB3' ' CG ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -65.94 -44.23 85.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.857 0.361 . . . . 0.0 110.739 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.68 53.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.63 ' CE2' HG21 ' A' ' 121' ' ' VAL . 70.1 t80 -71.05 -60.63 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.249 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.39 -47.53 4.96 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.517 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.458 ' CE2' ' CE1' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -54.57 -64.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.707 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 37.1 t-20 -48.56 -50.35 32.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.187 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.63 HG21 ' CE2' ' A' ' 117' ' ' PHE . 47.4 t -54.48 -44.81 69.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.479 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.1 p -54.85 -59.38 4.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.029 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 3.1 tp -47.03 -31.81 3.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 7.1 tp60 -74.59 -48.92 23.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.245 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.547 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 3.5 m-20 -49.07 -51.39 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.478 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 47.1 m170 -74.34 -41.59 60.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.316 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.673 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.09 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.821 0.343 . . . . 0.0 111.393 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HD3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -83.41 173.16 11.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.905 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -91.12 125.4 35.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.5 t -149.52 -46.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -87.99 61.45 6.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.316 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.49 85.43 6.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.875 0.369 . . . . 0.0 110.74 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.772 -179.776 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.666 0.27 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.6 -55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 111.132 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.13 45.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.515 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -149.21 10.91 0.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 5' ' ' LEU . 1.7 tp -150.29 75.03 1.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 110.155 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.5 105.32 5.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.738 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -80.95 128.41 33.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.876 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 83.92 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.683 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -158.18 127.49 5.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.968 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG23 ' H ' ' A' ' 12' ' ' CYS . 24.0 m -56.84 -43.21 79.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.964 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER 71.72 38.14 1.0 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.267 0.556 . . . . 0.0 111.986 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.729 ' HB3' HG12 ' A' ' 49' ' ' ILE . 12.4 t -84.31 140.71 31.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.71 ' O ' ' HD3' ' A' ' 14' ' ' LYS . 26.2 m -156.48 163.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.71 ' HD3' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -171.44 103.3 0.38 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 57.1 Cg_endo -71.79 -22.56 23.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.832 2.355 . . . . 0.0 112.977 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -118.93 97.11 5.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 18' ' ' SER . 11.0 p -158.51 154.2 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.339 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.765 ' HB2' ' HD1' ' A' ' 110' ' ' PHE . 8.8 t -120.43 139.81 52.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.428 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 p -134.7 145.34 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.398 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -109.51 158.36 18.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.958 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.408 ' H ' ' HB2' ' A' ' 41' ' ' PRO . 8.8 ttt180 -131.4 151.39 51.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.39 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.91 82.86 16.96 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.056 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 3.1 Cg_exo -42.18 -53.52 3.54 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.686 2.258 . . . . 0.0 112.794 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 41.4 Cg_endo -67.15 -166.19 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.299 2.0 . . . . 0.0 112.075 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -173.61 75.2 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.583 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' HH2' ' A' ' 36' ' ' TRP . . . -78.95 27.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.371 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.67 130.1 0.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -46.05 -33.86 3.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.282 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -146.35 154.32 41.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.94 150.45 51.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.519 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.723 ' CE1' HG21 ' A' ' 86' ' ' THR . 0.6 OUTLIER -167.13 127.37 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.326 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 69.06 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.151 0.5 . . . . 0.0 110.662 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.015 ' HB3' HG12 ' A' ' 85' ' ' VAL . . . -58.2 -39.47 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.543 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 0.6 OUTLIER -53.38 -25.5 15.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.062 0.458 . . . . 0.0 110.351 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.13 -23.06 16.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.914 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.561 ' HH2' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -76.13 -44.61 37.62 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.125 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER 61.06 149.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -175.41 61.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.024 0.44 . . . . 0.0 111.052 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -82.28 -14.81 54.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.346 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.449 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -89.62 -65.29 0.17 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.541 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 40' ' ' GLN . 40.4 Cg_endo -67.94 100.51 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.136 1.891 . . . . 0.0 111.605 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 13.1 p30 -173.12 75.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.795 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.699 ' HH2' HD13 ' A' ' 60' ' ' LEU . 1.3 p-90 -73.05 163.66 27.83 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.717 0.294 . . . . 0.0 110.892 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.1 t -121.5 138.19 54.4 Favored 'General case' 0 N--CA 1.461 0.082 0 CA-C-O 120.956 0.408 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -163.4 31.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.11 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -103.34 135.52 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.494 179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tp -123.82 142.89 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.301 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB2' HG12 ' A' ' 13' ' ' VAL . 2.5 ptt180 -159.85 172.14 18.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.951 0.405 . . . . 0.0 111.595 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.729 HG12 ' HB3' ' A' ' 12' ' ' CYS . 14.6 pt -150.42 156.35 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.845 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -161.9 167.66 24.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.73 -179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -137.92 127.35 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.134 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -57.82 11.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.42 -66.47 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.107 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -94.04 -15.25 24.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.758 0.313 . . . . 0.0 110.628 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -125.39 -177.4 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.684 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' H ' HG13 ' A' ' 55' ' ' ILE . . . -150.63 158.24 43.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -162.21 150.92 15.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.615 HG22 ' CG2' ' A' ' 49' ' ' ILE . 1.7 pp -104.11 131.29 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -111.26 135.76 51.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.977 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD13 ' HH2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -140.72 154.66 46.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.5 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -176.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.359 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -80.4 116.56 20.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.778 ' HE2' ' HB3' ' A' ' 15' ' ' PRO . 32.5 tptt -66.02 5.28 0.52 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.1 t -79.69 -48.91 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.232 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -168.21 -28.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.64 141.49 8.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.452 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.54 -77.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.0 111.197 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 mt -52.93 -65.75 0.5 Allowed 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.572 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 8.9 t80 74.71 135.63 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.301 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -172.06 156.43 4.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.799 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -165.54 176.4 8.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 110.947 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.13 95.27 6.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.647 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.72 156.49 65.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.493 2.129 . . . . 0.0 112.386 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 98' ' ' ASP . 26.1 m -138.95 165.1 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.349 0.595 . . . . 0.0 111.499 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.745 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 5.9 tp10 -73.29 -9.02 58.26 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.039 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.72 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 7.5 tm0? 65.87 135.52 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.665 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.2 t80 105.91 -50.16 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.681 0.613 . . . . 0.0 111.757 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.72 ' HD2' ' C ' ' A' ' 76' ' ' GLN . 60.1 Cg_endo -74.01 62.33 4.93 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.025 1.817 . . . . 0.0 112.445 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.66 124.14 7.39 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.587 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.631 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.9 OUTLIER -179.67 -169.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 95' ' ' ARG . . . 76.93 71.59 0.07 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.422 0.63 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 5.4 m -153.23 118.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.306 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 84' ' ' THR . 9.0 tt0 -153.26 -178.56 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.993 0.425 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.566 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 14.5 p -135.52 -160.17 1.03 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG12 ' HB3' ' A' ' 33' ' ' ALA . 1.6 m -72.6 108.68 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.628 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.723 HG21 ' CE1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.15 -38.67 83.85 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.211 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 7.43 46.34 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 6.4 t 64.66 108.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.918 ' HB3' HG11 ' A' ' 85' ' ' VAL . 38.0 t -124.78 -83.74 0.64 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.36 35.75 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.628 ' HE1' ' HB1' ' A' ' 33' ' ' ALA . 1.3 p90 -169.26 -173.9 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.69 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.824 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 2.4 p90 -143.58 158.38 43.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.835 0.35 . . . . 0.0 110.786 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.727 ' HB ' ' HE1' ' A' ' 105' ' ' PHE . 1.6 m -119.78 153.72 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.215 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -141.9 147.72 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.884 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.956 ' HB3' ' HA ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -147.95 175.23 11.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.377 -179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.598 ' O ' ' HB2' ' A' ' 103' ' ' SER . 56.5 mt -133.13 148.29 31.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.641 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HB3' HG22 ' A' ' 80' ' ' ILE . 15.0 tt0 -133.69 149.0 51.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.485 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.745 ' HB2' ' H ' ' A' ' 75' ' ' GLU . 7.6 p-10 -166.86 153.87 8.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 100' ' ' THR . . . 70.28 -20.56 0.57 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.742 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' ASP . 5.0 m 82.63 41.53 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 121.209 0.528 . . . . 0.0 109.636 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.34 -22.93 0.03 OUTLIER Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.253 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.463 HH11 ' HA ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -118.32 118.33 31.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 117.159 0.479 . . . . 0.0 110.553 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.598 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 3.3 p -148.66 141.17 24.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.96 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.96 137.24 48.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.801 0.334 . . . . 0.0 111.503 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 95' ' ' ARG . 2.2 t80 -113.83 126.88 55.68 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 108' ' ' ILE . 1.7 pt -140.42 159.44 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' VAL . . . -113.35 147.85 18.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.063 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 106' ' ' ILE . 3.4 mm -129.75 123.61 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.137 0.469 . . . . 0.0 111.651 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.44 112.87 0.4 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.894 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.765 ' HD1' ' HB2' ' A' ' 18' ' ' SER . 1.5 t80 -78.7 -176.63 5.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.52 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -65.12 -2.97 3.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.275 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -152.32 169.88 21.44 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.697 0.284 . . . . 0.0 110.583 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.5 ttt85 -89.44 10.76 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.168 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.54 -68.8 1.53 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.087 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 119' ' ' PHE . 2.4 m-20 -59.31 -33.65 71.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.737 0.303 . . . . 0.0 110.548 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -53.18 -60.59 3.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.488 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 121' ' ' VAL . 46.4 t80 -52.23 -63.05 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.769 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.43 -46.28 62.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.161 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.618 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -60.05 -52.35 65.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.003 0.43 . . . . 0.0 110.553 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.548 ' N ' ' CD1' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -58.07 -60.56 3.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.579 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.475 HG11 ' CE1' ' A' ' 117' ' ' PHE . 32.6 m -47.73 -33.28 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.797 0.332 . . . . 0.0 111.549 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.76 -53.1 52.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.915 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 127' ' ' PHE . 1.9 tt -51.72 -35.77 44.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -50.85 14.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 110.611 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -48.59 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.583 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.436 ' CE1' HD11 ' A' ' 11' ' ' LEU . 2.7 m-70 -72.6 -51.05 21.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.151 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -65.38 -79.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.726 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -78.49 153.66 31.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 111.076 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' TRP . 65.0 t-105 -146.01 57.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.919 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 130' ' ' VAL . 7.6 t -145.63 23.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -88.94 -21.38 23.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -160.03 139.93 11.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.998 179.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.724 0.297 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.79 -176.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.54 80.28 0.81 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.518 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -143.72 -8.99 0.72 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.702 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -88.09 74.42 8.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.31 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 7.4 mt-10 -148.0 97.97 2.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -159.71 -165.27 1.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.775 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.6 77.95 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -157.58 125.68 5.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.883 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 49' ' ' ILE . 27.8 m -56.14 -36.51 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 50' ' ' THR . 3.0 pp 44.94 35.33 1.49 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.62 ' HB3' HG12 ' A' ' 49' ' ' ILE . 41.4 t -76.82 139.67 40.42 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.625 HG11 ' NH1' ' A' ' 48' ' ' ARG . 4.2 m -154.26 160.36 2.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.991 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -170.37 81.47 0.58 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 57.4 Cg_endo -72.39 51.38 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.941 2.427 . . . . 0.0 113.357 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -170.92 76.07 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.16 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -164.52 168.49 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 111.837 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' H ' HG22 ' A' ' 17' ' ' VAL . 67.4 m -115.89 131.6 56.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.151 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.685 HG21 ' CZ3' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -100.81 168.82 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.07 -179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.512 ' OH ' ' HA3' ' A' ' 109' ' ' GLY . 21.3 m-85 -130.06 142.32 50.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.904 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HG3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -123.19 119.97 31.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.976 179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.56 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -111.49 116.48 50.56 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.723 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.632 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 35.3 Cg_endo -67.09 -29.67 39.59 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.379 2.053 . . . . 0.0 113.435 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HB2' ' CG ' ' A' ' 29' ' ' ARG . 55.9 Cg_endo -71.9 108.79 2.52 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.664 1.576 . . . . 0.0 112.263 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.8 mtp-105 -126.77 71.55 1.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.995 0.426 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.59 178.05 7.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.06 -65.92 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.957 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -83.15 55.91 3.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.372 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.673 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -131.24 13.27 5.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.06 -179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.33 144.74 15.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.353 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.14 143.89 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.891 0.377 . . . . 0.0 111.156 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 16.7 mmt-85 -67.67 163.74 20.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB2' ' HE1' ' A' ' 91' ' ' TYR . . . -61.42 -8.49 4.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.217 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.1 p -52.7 -41.18 63.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.14 0.495 . . . . 0.0 110.265 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -143.86 19.71 1.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CZ2' ' HB2' ' A' ' 38' ' ' LEU . 3.1 t90 -77.07 -61.03 2.12 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.118 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER 52.96 172.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 111.121 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 36' ' ' TRP . 6.6 tp -174.66 130.72 0.34 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.531 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -150.39 67.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.354 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.482 ' CB ' ' CD ' ' A' ' 41' ' ' PRO . 1.8 mt-30 -153.42 -65.73 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.609 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 92.3 Cg_endo -73.19 -95.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.624 2.216 . . . . 0.0 112.459 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 30.5 t70 45.75 56.21 6.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.068 0.461 . . . . 0.0 110.272 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -75.05 162.67 28.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.619 -179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 59.4 m -108.62 120.92 43.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.608 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' A' ' 62' ' ' ASP . . . -177.65 -174.19 43.79 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.831 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.847 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 19.0 ptt85 -117.25 160.47 21.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.389 0.614 . . . . 0.0 112.184 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.8 139.45 53.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.289 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.625 ' NH1' HG11 ' A' ' 13' ' ' VAL . 9.3 ttt180 -140.74 139.76 34.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.044 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.62 HG12 ' HB3' ' A' ' 12' ' ' CYS . 10.2 pt -135.08 152.08 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.528 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.792 HG23 ' HA ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -164.46 -176.73 4.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -156.91 131.06 8.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.723 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -53.34 58.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.3 -64.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -94.35 -19.34 20.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.708 0.289 . . . . 0.0 110.883 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.722 HG22 ' HA ' ' A' ' 75' ' ' GLU . 7.4 pt -123.62 177.37 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.0 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HB2' ' A' ' 76' ' ' GLN . . . -142.9 140.0 31.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 111.328 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -132.24 142.97 49.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.752 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.05 150.38 25.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.204 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.86 145.63 51.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.617 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.756 HD12 HD11 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -124.19 132.1 53.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.87 166.7 3.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.809 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.748 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 39.6 t0 -77.43 139.37 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.266 0.555 . . . . 0.0 111.691 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -66.01 -5.29 9.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.724 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.1 t -80.59 -59.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.04 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.3 t -175.14 68.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.23 89.08 0.02 OUTLIER Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.709 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.748 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 2.9 tt0 -73.36 -112.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.574 0.226 . . . . 0.0 111.447 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 60' ' ' LEU . 3.6 pp -62.42 -53.11 59.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.703 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER 90.47 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.814 0.446 . . . . 0.0 111.291 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 60' ' ' LEU . . . -166.06 155.32 11.68 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.256 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.85 157.05 43.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.75 101.3 23.76 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 130.15 17.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.452 2.102 . . . . 0.0 111.95 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 98' ' ' ASP . 2.2 t -132.62 154.82 40.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 111.567 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 55' ' ' ILE . 6.0 mm-40 -77.65 -2.93 38.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.484 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.518 ' HB2' ' N ' ' A' ' 56' ' ' ALA . 6.6 tm0? 53.8 78.91 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.898 0.38 . . . . 0.0 111.41 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.803 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -159.26 -65.67 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 77' ' ' TYR . 50.9 Cg_endo -70.82 59.5 2.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.984 1.789 . . . . 0.0 112.636 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.33 111.56 4.26 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.359 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.695 HG13 ' H ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -179.32 -142.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.741 ' HB1' ' HB3' ' A' ' 95' ' ' ARG . . . 64.68 65.54 0.62 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 m -144.57 132.74 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.482 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -136.78 143.9 43.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.905 0.384 . . . . 0.0 110.745 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.84 175.86 5.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.625 0.726 . . . . 0.0 110.994 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' H ' ' A' ' 89' ' ' SER . 6.4 m -70.24 106.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.586 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -64.11 -36.32 83.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.532 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -99.36 12.78 35.35 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.648 0.261 . . . . 0.0 111.492 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m 65.38 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 111.217 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.597 ' H ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -139.1 169.2 18.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.73 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.727 ' HD3' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -78.51 28.88 0.19 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HE1' ' HB2' ' A' ' 33' ' ' ALA . 0.5 OUTLIER -148.73 -171.62 3.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.661 ' CD2' HG13 ' A' ' 108' ' ' ILE . 1.7 p90 -167.31 165.67 15.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 t -117.23 139.62 43.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.415 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 HG22 HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -133.25 140.04 47.91 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.008 0.432 . . . . 0.0 111.082 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 105' ' ' PHE . 5.8 ttt180 -143.11 162.94 34.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.746 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 103' ' ' SER . 23.4 mm -124.39 147.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 103' ' ' SER . 3.1 tt0 -115.5 136.73 52.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 110.99 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.528 ' CB ' HG13 ' A' ' 74' ' ' VAL . 43.8 t0 -124.88 105.31 9.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.987 0.422 . . . . 0.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.621 ' C ' HG23 ' A' ' 100' ' ' THR . . . 66.64 2.64 16.94 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.312 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.726 HG22 ' HB3' ' A' ' 78' ' ' PRO . 1.4 p 82.81 -27.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 117.02 0.41 . . . . 0.0 111.029 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.54 -57.76 3.5 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -109.29 137.93 46.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.927 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.735 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -160.96 159.57 29.7 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -134.56 140.34 46.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.597 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.77 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -113.89 154.36 27.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 111.874 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 105' ' ' PHE . 4.2 mm -146.46 163.81 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.929 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' TYR . . . -107.36 138.33 14.46 Favored Glycine 0 C--O 1.225 -0.458 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.06 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.661 HG13 ' CD2' ' A' ' 92' ' ' PHE . 6.6 pt -134.54 143.2 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.726 0.298 . . . . 0.0 110.925 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . -174.09 -166.88 32.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.993 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -155.56 163.29 40.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 111.037 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -66.07 -3.86 6.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.437 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.61 165.11 32.27 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.815 0.34 . . . . 0.0 110.756 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.11 -31.31 21.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.014 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -55.23 -56.42 23.38 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.353 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.46 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -64.33 -47.82 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.552 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 92' ' ' PHE . . . -52.73 -22.84 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.265 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.532 ' O ' HG22 ' A' ' 121' ' ' VAL . 52.8 t80 -75.23 -57.34 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.871 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -50.17 -43.31 52.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.587 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -64.96 -61.0 2.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.817 0.341 . . . . 0.0 110.546 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.535 ' N ' ' CD2' ' A' ' 119' ' ' PHE . 1.5 m-80 -48.02 -49.95 29.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.604 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 117' ' ' PHE . 32.2 m -64.77 -24.73 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.4 p -69.81 -51.81 30.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 12' ' ' CYS . 2.3 tt -58.83 -37.74 77.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.527 ' HG3' ' HE3' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -66.53 -54.46 23.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.064 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -51.61 -40.68 60.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.481 ' CE1' HD12 ' A' ' 11' ' ' LEU . 32.1 m170 -70.18 -52.15 25.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -64.64 -82.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.52 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.527 ' HE3' ' HG3' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.26 145.15 25.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.705 0.288 . . . . 0.0 110.84 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 9.1 t-105 -153.68 91.06 1.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.896 0.379 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.4 t -153.57 -54.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -93.1 35.48 1.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.94 113.82 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.837 179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.894 0.378 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.92 86.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.314 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.24 62.12 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.193 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.37 146.77 25.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.22 55.19 2.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -152.85 84.77 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.21 85.2 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -160.09 136.8 9.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -162.84 172.04 15.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.676 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 2.1 t -58.54 -63.71 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.006 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER 81.34 89.58 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.879 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' CB ' HG13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.44 132.86 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.535 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.863 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -154.79 158.62 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -170.22 88.92 0.53 Allowed Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.677 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.649 ' HA ' ' CB ' ' A' ' 46' ' ' ARG . 73.5 Cg_endo -74.59 -16.6 21.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.691 2.261 . . . . 0.0 113.011 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 115' ' ' ASP . 53.7 m-20 -113.22 91.47 3.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.662 0.268 . . . . 0.0 110.34 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' CG1' ' HG ' ' A' ' 47' ' ' LEU . 9.7 p -166.0 157.62 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.875 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.6 t -117.13 128.13 54.82 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 107' ' ' GLY . 0.9 OUTLIER -118.9 144.41 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.455 -179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.71 ' CE2' HD11 ' A' ' 22' ' ' ILE . 52.6 p90 -118.75 164.13 15.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.544 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.693 ' C ' HD13 ' A' ' 22' ' ' ILE . 2.8 ttp85 -132.94 149.23 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.71 HD11 ' CE2' ' A' ' 20' ' ' TYR . 0.5 OUTLIER -113.47 94.49 32.11 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.034 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.1 Cg_endo -42.92 -47.7 8.05 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.746 2.297 . . . . 0.0 112.507 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 23' ' ' PRO . 37.0 Cg_endo -65.19 156.71 61.5 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.009 1.806 . . . . 0.0 112.13 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -96.34 143.67 27.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.022 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.25 86.45 1.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.032 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.0 p -57.06 -50.27 73.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.039 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -84.77 -73.38 0.43 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.428 ' HD2' ' OE1' ' A' ' 83' ' ' GLU . 8.7 ttp180 -161.3 178.5 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.0 -85.87 0.81 Allowed Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.201 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' HB2' ' CZ3' ' A' ' 36' ' ' TRP . 3.2 m-85 -166.0 149.11 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.827 0.346 . . . . 0.0 110.383 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HB2' ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -63.63 161.38 14.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.66 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . . . -60.58 -1.36 0.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.1 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -60.56 -32.51 71.58 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.08 0.466 . . . . 0.0 109.916 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -146.41 15.14 1.28 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.559 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CZ3' ' HB2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -73.98 -49.69 23.32 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 121.192 -0.203 . . . . 0.0 110.52 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' TRP . 1.7 mmtm 54.54 151.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.231 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -173.4 57.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.13 0.491 . . . . 0.0 111.137 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.76 -18.93 46.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.708 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -91.03 -63.14 0.19 Allowed Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.393 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 40' ' ' GLN . 49.7 Cg_endo -68.66 100.64 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.914 1.743 . . . . 0.0 112.348 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.8 75.63 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.46 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.551 ' CD2' HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -74.95 162.08 28.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.82 0.343 . . . . 0.0 110.955 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.96 129.64 56.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.91 -173.36 43.28 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.802 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.875 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -102.6 135.96 43.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 111.06 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -125.98 145.59 50.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -164.09 170.27 16.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.931 -178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG13 ' CB ' ' A' ' 12' ' ' CYS . 2.6 pt -141.8 153.23 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.243 0.544 . . . . 0.0 110.626 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 p -150.79 157.2 42.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.556 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 17.4 m -145.21 127.13 15.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -57.0 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.28 -55.51 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.436 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' H ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -96.73 -11.81 24.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 111.071 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG13 ' H ' ' A' ' 56' ' ' ALA . 7.0 tp -132.49 167.63 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.927 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.761 ' O ' HG22 ' A' ' 74' ' ' VAL . . . -141.54 151.31 43.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -154.7 147.55 24.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.02 0.438 . . . . 0.0 111.578 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' C ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -102.44 136.5 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.984 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 48' ' ' ARG . 13.1 ttmt -120.51 135.71 54.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.643 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -127.96 149.99 50.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.029 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' OE1' ' HG2' ' A' ' 59' ' ' LYS . 3.5 pm0 -176.28 -174.25 0.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.124 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.642 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 31.8 t0 -96.73 127.92 43.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 111.402 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -63.15 3.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.303 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 51.1 t -85.11 -57.31 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.0 p -175.37 59.75 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.727 0.299 . . . . 0.0 111.601 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.57 94.76 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.671 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.642 ' HB2' ' CB ' ' A' ' 62' ' ' ASP . 1.3 tt0 -78.24 -163.27 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.011 0.434 . . . . 0.0 110.54 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.46 -29.1 0.14 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.433 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 78.8 127.26 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 111.218 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -167.83 145.68 4.46 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 2.6 mp0 -148.98 176.79 10.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.98 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.47 97.74 3.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.578 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.2 143.57 65.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.371 2.048 . . . . 0.0 112.14 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.013 HG11 HG21 ' A' ' 96' ' ' ILE . 4.9 m -127.7 161.32 35.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 55' ' ' ILE . 46.5 tp10 -71.81 -11.34 60.76 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.612 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.761 ' C ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 61.91 130.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.624 ' CB ' ' O ' ' A' ' 76' ' ' GLN . 2.6 t80 105.02 -46.39 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.903 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 98.3 Cg_endo -75.03 69.06 5.67 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.223 1.948 . . . . 0.0 112.602 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.95 9.61 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.572 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.649 HG22 ' HB2' ' A' ' 97' ' ' GLN . 1.3 tp -177.99 -177.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.682 ' C ' ' HD3' ' A' ' 95' ' ' ARG . . . 63.53 68.99 0.57 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.471 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -149.36 131.84 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.345 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HD2' ' A' ' 29' ' ' ARG . 3.1 mt-10 -150.38 165.31 33.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.065 0.46 . . . . 0.0 110.91 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -133.82 -167.5 1.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.781 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 91' ' ' TYR . 6.3 m -70.7 96.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.289 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 m -61.83 -6.46 2.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 32' ' ' ARG . 13.5 p-10 -148.31 18.98 1.08 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.44 150.2 0.07 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 111.73 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.4 t -178.39 -92.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.123 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -179.77 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -164.64 -179.44 5.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.497 ' CZ ' ' CZ ' ' A' ' 119' ' ' PHE . 7.7 p90 -161.25 164.84 30.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.765 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG12 ' OH ' ' A' ' 20' ' ' TYR . 34.7 m -118.84 138.52 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.614 ' C ' ' HG3' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -136.22 140.93 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -148.95 179.91 7.51 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.785 -179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.013 HG21 HG11 ' A' ' 74' ' ' VAL . 8.8 mt -139.36 167.13 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.266 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.649 ' HB2' HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -130.91 157.11 43.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.389 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 102' ' ' ARG . 7.0 t70 -128.92 87.36 2.56 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.896 0.379 . . . . 0.0 111.475 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.903 ' H ' ' HG3' ' A' ' 78' ' ' PRO . . . 51.67 19.46 4.8 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.682 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.497 HG23 ' C ' ' A' ' 99' ' ' GLY . 2.0 p 79.06 55.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.372 0.606 . . . . 0.0 109.57 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.01 -32.46 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.209 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -129.47 107.89 9.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.377 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 97' ' ' GLN . 2.0 p -135.79 129.17 32.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.68 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . -112.89 136.56 52.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.584 ' HA ' ' HG2' ' A' ' 95' ' ' ARG . 3.2 t80 -108.99 133.65 52.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.115 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 107' ' ' GLY . 0.5 OUTLIER -140.22 169.99 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.138 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.666 ' HA3' ' CE2' ' A' ' 20' ' ' TYR . . . -128.56 138.29 10.23 Favored Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.283 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.575 HD12 HG21 ' A' ' 94' ' ' ILE . 8.3 mt -142.42 149.66 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 117.121 0.46 . . . . 0.0 111.738 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.97 -164.67 30.62 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.679 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CG ' ' HB2' ' A' ' 115' ' ' ASP . 20.5 t80 -163.69 169.45 18.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.091 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.7 p -65.08 -74.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -85.53 178.43 7.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.27 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.36 13.66 1.85 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.639 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.76 -67.25 1.94 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HB2' ' CG ' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -53.13 -38.67 62.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.821 0.343 . . . . 0.0 110.899 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.52 ' O ' ' HD1' ' A' ' 119' ' ' PHE . . . -52.05 -61.36 2.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.4 t80 -49.02 -45.53 42.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.74 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -67.39 -49.23 64.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.621 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.52 ' HD1' ' O ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -61.86 -35.85 79.51 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.834 0.349 . . . . 0.0 110.483 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -64.29 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.374 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 117' ' ' PHE . 18.9 m -45.25 -39.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.572 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 m -63.54 -43.05 98.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 110.816 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 126' ' ' HIS . 1.3 mp -55.47 -34.71 64.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.021 0.439 . . . . 0.0 110.574 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -78.17 -21.97 49.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.293 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.53 -54.36 24.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.313 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' HB2' HG13 ' A' ' 10' ' ' VAL . 34.7 p80 -66.19 -49.12 68.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.85 -78.74 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.73 -0.213 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 124' ' ' GLN . 12.7 mmtt -60.25 125.13 22.48 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.202 0.525 . . . . 0.0 111.406 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.44 ' O ' ' HD1' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -88.29 130.49 35.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.563 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.1 t -143.57 -62.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -149.23 -169.59 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 8.3 mt-30 -150.71 107.36 3.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.904 179.856 . . . . . . . . 1 1 . 1 stop_ save_